{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:20:23Z","timestamp":1788250823701,"version":"build-2803163510"},"reference-count":377,"publisher":"American Chemical Society (ACS)","issue":"16","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22337003"],"award-info":[{"award-number":["22337003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82121005"],"award-info":[{"award-number":["82121005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130105"],"award-info":[{"award-number":["82130105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341091"],"award-info":[{"award-number":["82341091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2023292"],"award-info":[{"award-number":["2023292"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the first confirmed case in 1970, the monkeypox virus (MPXV) has emerged as a significant threat to global public health. The World Health Organization (WHO) has declared it a Public Health Emergency of International Concern (PHEIC) on two occasions. Despite decades of research, only tecovirimat has been approved by the European Medicines Agency (EMA) for the treatment of MPXV infection. The genome and structure are similar between MPXV and other orthopoxviruses (OPXVs), suggesting that the strategies used for other OPXVs may be applicable to MPXV. This review systematically summarizes the genome, structure, and critical stages in the life cycle of OPXVs, especially MPXV. A variety of antiviral agents against MPXV and other OPXVs are discussed according to their distinct mechanisms of action: 1) blocking viral entry and fusion, 2) inhibiting DNA replication and processing, 3) disrupting transcription and mRNA processing, 4) preventing virion assembly, maturation and release, 5) modulating immune responses, and 6) mechanism unknown. Overall, this article provides a systematic review of current research progress on potential therapeutic targets and agent for MPXV, aiming to offer innovative insights and strategies for the development of effective therapeutic agents against mpox.<\/jats:p>","DOI":"10.1021\/acs.chemrev.6c00118","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:01:21Z","timestamp":1786737681000},"page":"9307-9356","source":"Crossref","is-referenced-by-count":0,"title":["Insights into\nthe Life Cycle and Therapeutic Agents\nfor Monkeypox Virus Infection"],"prefix":"10.1021","volume":"126","author":[{"given":"Qiuyu","family":"Zhong","sequence":"first","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 210009"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulei","family":"Hu","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 210009"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Xie","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , ,","place":["Beijing, China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"He","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 210009"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , ,","place":["Beijing, China, 100049"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Shou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8508-7130","authenticated-orcid":true,"given":"Wenhao","family":"Dai","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , ,","place":["Beijing, China, 100049"]},{"name":"Hangzhou Institute for Advanced Study, UCAS , , ,","place":["Hangzhou, China, 310024"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-6268","authenticated-orcid":true,"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 210009"]},{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , 555 Zu Chong Zhi Road , ,","place":["Shanghai, China, 201203"]},{"name":"University of Chinese Academy of Sciences , ,","place":["Beijing, China, 100049"]},{"name":"Hangzhou Institute for Advanced Study, UCAS , , ,","place":["Hangzhou, China, 310024"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"3","key":"2026090104121830600_cit1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1469-0691.12536","article-title":"The Rediscovery of Smallpox","volume":"20","author":"The\u0300ves","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"227","key":"2026090104121830600_cit2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S002086040006808X","article-title":"Smallpox Eradication","volume":"22","year":"1982","journal-title":"Int. Rev. Red Cross"},{"issue":"1","key":"2026090104121830600_cit3","doi-asserted-by":"publisher","first-page":"2387442","DOI":"10.1080\/22221751.2024.2387442","article-title":"Global Perspectives\non Smallpox Vaccine against Monkeypox: A Comprehensive Meta-Analysis\nand Systematic Review of Effectiveness, Protection, Safety and Cross-Immunogenicity","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"22","key":"2026090104121830600_cit4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJM198011273032204","article-title":"The Confirmation and Maintenance\nof Smallpox Eradication","volume":"303","author":"Breman","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"2026090104121830600_cit5","unstructured":"Multi-Country-Outbreak-of-Mpox--External-Situation-Report_61.Pdf. https:\/\/cdn.who.int\/media\/docs\/default-source\/_sage-2026\/multi-country-outbreak-of-mpox--external-situation-report_61.pdf?sfvrsn=c1b8c9f1_3&download=true (accessed 2025-12-28)."},{"issue":"10380","key":"2026090104121830600_cit6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in People with\nAdvanced HIV Infection: A Global Case Series","volume":"401","author":"Mitja\u0300","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"2026090104121830600_cit7","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1038\/s41467-024-51737-4","article-title":"Evolutionary Trajectory and Characteristics of Mpox\nVirus in 2023\nBased on a Large-Scale Genomic Surveillance in Shenzhen, China","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"2026090104121830600_cit8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijid.2022.11.040","article-title":"The Use\nof Antivirals\nin the Treatment of Human Monkeypox Outbreaks: A Systematic Review","volume":"127","author":"Shamim","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"2026090104121830600_cit9","unstructured":"Lenharo, M.\n          \n          Hopes Dashed for\nDrug Aimed at Monkeypox Virus Spreading in Africa."},{"issue":"3","key":"2026090104121830600_cit10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia Immune\nGlobulin: Current Policies, Preparedness, and Product Safety and Efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"Int. J. Infect. Dis."},{"issue":"22","key":"2026090104121830600_cit11","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.cell.2025.07.040","article-title":"Structural\nBasis of Poxvirus Fusion Regulation and Anti-A16\/G9 Antibody-Mediated\nNeutralization and Protection","volume":"188","author":"Meola","year":"2025","journal-title":"Cell"},{"issue":"22","key":"2026090104121830600_cit12","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1016\/j.cell.2025.08.005","article-title":"Structurally Conserved Human Anti-A35 Antibodies Protect Mice and\nMacaques from Mpox Virus Infection","volume":"188","author":"Ju","year":"2025","journal-title":"Cell"},{"issue":"22","key":"2026090104121830600_cit13","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1016\/j.cell.2025.08.004","article-title":"Human Monoclonal Antibodies Targeting A35 Protect from\nDeath Caused by Mpox","volume":"188","author":"Fantin","year":"2025","journal-title":"Cell"},{"issue":"1","key":"2026090104121830600_cit14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tips.2022.10.005","article-title":"Monkeypox: Potential\nVaccine Development Strategies","volume":"44","author":"Lozano","year":"2023","journal-title":"Trends Pharmacol.\nSci."},{"key":"2026090104121830600_cit15","unstructured":"Ziegler, P.; Kima, E.\n          A Human Infection Caused by\nMonkeypox Virus in Basankusu Territory, Democratic Republic of the\nCongo."},{"key":"2026090104121830600_cit16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26531","article-title":"Monkeypox: A Comprehensive\nReview of Transmission, Pathogenesis, and Manifestation","author":"Kaler","year":"2022","journal-title":"Cureus"},{"issue":"7","key":"2026090104121830600_cit17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/378357","article-title":"Effectiveness of Postexposure Vaccination\nfor the Prevention of Smallpox: Results of a Delphi Analysis","volume":"188","author":"Massoudi","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"2026090104121830600_cit18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2023.11.001","article-title":"Monkeypox Virus (MPXV): A Brief Account\nof Global Spread, Epidemiology, Virology, Clinical Features, Pathogenesis,\nand Therapeutic Interventions","volume":"2","author":"Islam","year":"2023","journal-title":"Infect. Med."},{"issue":"2","key":"2026090104121830600_cit19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","article-title":"The Changing Epidemiology of Human\nMonkeypox\u2500A Potential Threat? A Systematic Review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"2026090104121830600_cit20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2406.180017","article-title":"Reemergence\nof Human Monkeypox in Nigeria,\n2017","volume":"24","author":"Yinka-Ogunleye","year":"2018","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"2026090104121830600_cit21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3201\/eid2602.191139","article-title":"Use of Surveillance\nOutbreak Response\nManagement and Analysis System for Human Monkeypox Outbreak, Nigeria,\n2017\u20132019","volume":"26","author":"Silenou","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"2026090104121830600_cit22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The Detection of\nMonkeypox in Humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2026090104121830600_cit23","first-page":"115","article-title":"The Role of\nSquirrels in Sustaining\nMonkeypox Virus Transmission","volume":"39","author":"Khodakevich","year":"1987","journal-title":"Trop Geogr Med."},{"issue":"10","key":"2026090104121830600_cit24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/v9100283","article-title":"Assessing\nMonkeypox Virus Prevalence in Small Mammals at the Human\u2013Animal\nInterface in the Democratic Republic of the Congo","volume":"9","author":"Doty","year":"2017","journal-title":"Viruses"},{"issue":"6","key":"2026090104121830600_cit25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3201\/eid2206.150579","article-title":"Extended Human-to-Human Transmission during\na Monkeypox Outbreak in the Democratic Republic of the Congo","volume":"22","author":"Nolen","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"9","key":"2026090104121830600_cit26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41579-022-00776-z","article-title":"Monkeypox Virus:\nA Neglected Zoonotic Pathogen Spreads\nGlobally","volume":"20","author":"Alakunle","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"2026090104121830600_cit27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic\nCharacterization and Signs of Microevolution\nin the 2022 Multi-Country Outbreak of Monkeypox Virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"2026090104121830600_cit28","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28036","article-title":"Genomic Annotation\nand Molecular\nEvolution of Monkeypox Virus Outbreak in 2022","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"issue":"10","key":"2026090104121830600_cit29","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/infdis\/jiad165","article-title":"APOBEC3F Is a Mutational Driver of the Human Monkeypox\nVirus Identified in the 2022 Outbreak","volume":"228","author":"Suspe\u0300ne","year":"2023","journal-title":"J. Infect.\nDis."},{"issue":"10472","key":"2026090104121830600_cit30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(24)02353-5","article-title":"Concurrent Outbreaks of Mpox in Africa\u2500an Update","volume":"405","author":"Beiras","year":"2025","journal-title":"Lancet"},{"issue":"19","key":"2026090104121830600_cit31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.15585\/mmwr.mm7319a3","article-title":"U.S. Preparedness\nand\nResponse to Increasing Clade I Mpox Cases in the Democratic Republic\nof the Congo \u2500 United States, 2024","volume":"73","author":"McQuiston","year":"2024","journal-title":"MMWR\nMorb. Mortal. Wkly. Rep."},{"key":"2026090104121830600_cit32","volume-title":"Epidemiology of Human Monkeypox (Mpox) \u2013\nWorldwide,\n2018\u20132021","author":"McCollum"},{"key":"2026090104121830600_cit33","unstructured":"2022\u201324 mpox\n(monkeypox) outbreak: Global trends. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/ (accessed 2025-01-19)."},{"issue":"1","key":"2026090104121830600_cit34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals\nWith Activity Against Mpox: A Clinically\nOriented Review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"2026090104121830600_cit35","doi-asserted-by":"crossref","DOI":"10.5772\/60511","article-title":"Negative and Positive Staining in Transmission Electron\nMicroscopy\nfor Virus Diagnosis","volume-title":"Microbiology in Agriculture\nand Human Health","author":"Barreto-Vieira","year":"2015"},{"issue":"9","key":"2026090104121830600_cit36","doi-asserted-by":"publisher","first-page":"a010199","DOI":"10.1101\/cshperspect.a010199","article-title":"Poxvirus DNA\nReplication","volume":"5","author":"Moss","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"2026090104121830600_cit37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42649-022-00080-3","article-title":"Poxvirus under\nthe Eyes of Electron Microscope","volume":"52","author":"Hyun","year":"2022","journal-title":"Appl. Microsc."},{"key":"2026090104121830600_cit38","first-page":"31","article-title":"In a Nutshell:\nStructure and Assembly of the Vaccinia Virion","volume-title":"Advances in Virus Research","author":"Condit","year":"2006"},{"issue":"7","key":"2026090104121830600_cit39","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1091\/mbc.11.7.2497","article-title":"Entry of the Two Infectious Forms\nof Vaccinia Virus at the Plasma Membane Is Signaling-Dependent for\nthe IMV but Not the EEV","volume":"11","author":"Locker","year":"2000","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"2026090104121830600_cit40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/02648725.2018.1471643","article-title":"Vaccinia-Based Vaccines\nto Biothreat and Emerging Viruses","volume":"34","author":"Nagata","year":"2018","journal-title":"Biotechnol.\nGenet. Eng. Rev."},{"issue":"1","key":"2026090104121830600_cit41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox Vaccines:\nTargets of Protective Immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"issue":"3","key":"2026090104121830600_cit42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus Tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"2026090104121830600_cit43","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/v15122396","article-title":"Neutralization Determinants\non Poxviruses","volume":"15","author":"Riccardo","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"2026090104121830600_cit44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","article-title":"Human\nMonkeypox and Smallpox Viruses: Genomic\nComparison","volume":"509","author":"Shchelkunov","year":"2001","journal-title":"FEBS Lett."},{"issue":"1","key":"2026090104121830600_cit45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1743-422X-6-188","article-title":"Inhibition of Monkeypox\nVirus Replication by RNA Interference","volume":"6","author":"Alkhalil","year":"2009","journal-title":"Virol.\nJ."},{"key":"2026090104121830600_cit46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/524743","article-title":"Orthopoxvirus\nGenes That Mediate Disease Virulence and Host Tropism","volume":"2012","author":"Shchelkunov","year":"2012","journal-title":"Adv. Virol."},{"key":"2026090104121830600_cit47","doi-asserted-by":"crossref","volume-title":"Analysis of the Monkeypox Virus Genome","author":"Shchelkunov","DOI":"10.1006\/viro.2002.1446"},{"issue":"1","key":"2026090104121830600_cit48","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1080\/22221751.2022.2132882","article-title":"Comprehensive Literature\nReview of\nMonkeypox","volume":"11","author":"Hatmal","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"2026090104121830600_cit49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane Fusion\nduring Poxvirus Entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"2026090104121830600_cit50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coviro.2011.11.007","article-title":"Poxvirus Host\nCell Entry","volume":"2","author":"Schmidt","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"17","key":"2026090104121830600_cit51","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1038\/emboj.2011.245","article-title":"Vaccinia Extracellular\nVirions Enter Cells by Macropinocytosis and Acid-Activated Membrane\nRupture: Cell Entry of Vaccinia Extracellular Virions","volume":"30","author":"Schmidt","year":"2011","journal-title":"EMBO J."},{"issue":"5875","key":"2026090104121830600_cit52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.1155164","article-title":"Vaccinia Virus Uses\nMacropinocytosis and Apoptotic\nMimicry to Enter Host Cells","volume":"320","author":"Mercer","year":"2008","journal-title":"Science"},{"issue":"20","key":"2026090104121830600_cit53","doi-asserted-by":"publisher","first-page":"9346","DOI":"10.1073\/pnas.1004618107","article-title":"Vaccinia Virus Strains Use Distinct Forms of Macropinocytosis\nfor Host-Cell Entry","volume":"107","author":"Mercer","year":"2010","journal-title":"Proc. Natl. Acad. Sci.\nU. S. A."},{"issue":"6","key":"2026090104121830600_cit54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007826","article-title":"Vaccinia viral A26 protein is a fusion\nsuppressor of mature virus and triggers membrane fusion through conformational\nchange at low pH","volume":"15","author":"Chang","year":"2019","journal-title":"PLoS Pathog."},{"issue":"17","key":"2026090104121830600_cit55","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1128\/JVI.00599-10","article-title":"Vaccinia Virus\nA25 and A26 Proteins Are Fusion Suppressors for Mature Virions and\nDetermine Strain-Specific Virus Entry Pathways into HeLa, CHO-K1,\nand L Cells","volume":"84","author":"Chang","year":"2010","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit56","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1128\/JVI.02878-15","article-title":"Linear\nEpitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies\nInduced by Vaccination against Smallpox","volume":"90","author":"Kaever","year":"2016","journal-title":"J.\nVirol."},{"issue":"17","key":"2026090104121830600_cit57","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.1128\/JVI.00852-08","article-title":"Vaccinia Virus L1 Protein Is Required\nfor Cell Entry and Membrane Fusion","volume":"82","author":"Bisht","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"2026090104121830600_cit58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0022-2836(64)80136-4","article-title":"The Intracellular\nUncoating of Poxvirus DNA: I. The Fate of Radioactively-Labeled Rabbitpox\nVirus","volume":"8","author":"Joklik","year":"1964","journal-title":"J. Mol. Biol."},{"issue":"2","key":"2026090104121830600_cit59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0022-2836(64)80137-6","article-title":"The Intracellular\nUncoating of Poxvirus DNA: II. The Molecular Basis of the Uncoating\nProcess","volume":"8","author":"Joklik","year":"1964","journal-title":"J. Mol. Biol."},{"issue":"7","key":"2026090104121830600_cit60","doi-asserted-by":"publisher","first-page":"e02152","DOI":"10.1128\/JVI.02152-17","article-title":"Identification of Poxvirus\nGenome Uncoating and DNA Replication Factors\nwith Mutually Redundant Roles","volume":"92","author":"Liu","year":"2018","journal-title":"J. Virol."},{"issue":"1","key":"2026090104121830600_cit61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chom.2013.12.008","article-title":"siRNA Screen of Early Poxvirus Genes Identifies the\nAAA+ ATPase D5 as the Virus Genome-Uncoating Factor","volume":"15","author":"Kilcher","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"7","key":"2026090104121830600_cit62","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41594-024-01331-5","article-title":"Structure\nof the Poxvirus Core","volume":"31","author":"Coulibaly","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"18","key":"2026090104121830600_cit63","doi-asserted-by":"publisher","first-page":"8899","DOI":"10.1128\/JVI.01053-06","article-title":"Vaccinia Virus Entry\ninto Cells via a Low-pH-Dependent Endosomal Pathway","volume":"80","author":"Townsley","year":"2006","journal-title":"J. Virol."},{"issue":"4","key":"2026090104121830600_cit64","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2012.09.003","article-title":"RNAi Screening Reveals\nProteasome- and Cullin3-Dependent Stages in Vaccinia Virus Infection","volume":"2","author":"Mercer","year":"2012","journal-title":"Cell Rep."},{"issue":"9","key":"2026090104121830600_cit65","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The Interferon System\nand Vaccinia Virus Evasion Mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J. Interferon\nCytokine Res."},{"issue":"3","key":"2026090104121830600_cit66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/jvi.26.3.554-569.1978","article-title":"Sequence Complexity and Relative Abundance of Vaccinia Virus mRNA\u2019s\nSynthesized in Vivo and in Vitro","volume":"26","author":"Boone","year":"1978","journal-title":"J. Virol."},{"issue":"5","key":"2026090104121830600_cit67","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1021\/jm00109a001","article-title":"S-Adenosyl-L-Homocysteine Hydrolase as a Target for\nAntiviral Chemotherapy","volume":"34","author":"Wolfe","year":"1991","journal-title":"J. Med. Chem."},{"issue":"10\u201312","key":"2026090104121830600_cit68","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/15257770500265638","article-title":"John Montgomery\u2019s Legacy: Carbocyclic Adenosine Analogues\nas Sah Hydrolase Inhibitors with Broad-Spectrum Antiviral Activity","volume":"24","author":"De Clercq","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"36","key":"2026090104121830600_cit69","doi-asserted-by":"publisher","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization\nof Human Type I and Type II IMP Dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"4","key":"2026090104121830600_cit70","doi-asserted-by":"publisher","first-page":"e00566","DOI":"10.1128\/spectrum.00566-23","article-title":"Identification\nof IMP Dehydrogenase as a Potential\nTarget for Anti-Mpox Virus Agents","volume":"11","author":"Hishiki","year":"2023","journal-title":"Microbiol.\nSpectr."},{"issue":"5","key":"2026090104121830600_cit71","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/v2051050","article-title":"Surf and\nTurf: Mechanism of Enhanced Virus Spread During Poxvirus Infection","volume":"2","author":"Condit","year":"2010","journal-title":"Viruses"},{"issue":"2","key":"2026090104121830600_cit72","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1128\/jvi.18.2.636-643.1976","article-title":"High-Voltage\nElectron Microscope Study of the Release of Vaccinia Virus from Whole\nCells","volume":"18","author":"Stokes","year":"1976","journal-title":"J. Virol."},{"issue":"6557","key":"2026090104121830600_cit73","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/378636a0","article-title":"Actin-Based Motility\nof Vaccinia Virus","volume":"378","author":"Cudmore","year":"1995","journal-title":"Nature"},{"issue":"10","key":"2026090104121830600_cit74","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1128\/jvi.64.10.4884-4892.1990","article-title":"Fusion of Intra- and Extracellular\nForms of Vaccinia Virus with the Cell Membrane","volume":"64","author":"Doms","year":"1990","journal-title":"J. Virol."},{"issue":"5","key":"2026090104121830600_cit75","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1099\/vir.0.80831-0","article-title":"Entry of the Vaccinia Virus Intracellular\nMature Virion and Its Interactions with Glycosaminoglycans","volume":"86","author":"Carter","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"1","key":"2026090104121830600_cit76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/JVI.80.1.51-61.2006","article-title":"Entry of Vaccinia Virus and Cell-Cell\nFusion Require a Highly Conserved Cysteine-Rich Membrane Protein Encoded\nby the A16L Gene","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"15","key":"2026090104121830600_cit77","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1128\/JVI.79.15.9458-9469.2005","article-title":"Vaccinia Virus A21 Virion Membrane\nProtein Is Required for Cell Entry and Fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"issue":"11","key":"2026090104121830600_cit78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011500","article-title":"Structural\nand Functional Analysis of Vaccinia Viral Fusion Complex Component\nProtein A28 through NMR and Molecular Dynamic Simulations","volume":"19","author":"Kao","year":"2023","journal-title":"PLOS Pathog."},{"issue":"2","key":"2026090104121830600_cit79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.virol.2011.01.014","article-title":"Interaction between\nthe G3 and L5 Proteins of the Vaccinia Virus\nEntry\u2013Fusion Complex","volume":"412","author":"Wolfe","year":"2011","journal-title":"Virology"},{"issue":"10","key":"2026090104121830600_cit80","doi-asserted-by":"publisher","first-page":"e00093","DOI":"10.1128\/JVI.00093-20","article-title":"Experimental Evolution To Isolate\nVaccinia Virus Adaptive G9Mutants That Overcome Membrane Fusion Inhibition\nvia the Vaccinia Virus A56\/K2 Protein Complex","volume":"94","author":"Hong","year":"2020","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit81","doi-asserted-by":"publisher","first-page":"e00723","DOI":"10.1128\/jvi.00723-25","article-title":"Structural Dissection of Vaccinia\nG9 Identifies Residues Essential for Membrane Fusion and Complex Assembly","volume":"99","author":"Chiu","year":"2025","journal-title":"J. Virol."},{"issue":"19","key":"2026090104121830600_cit82","doi-asserted-by":"publisher","first-page":"9822","DOI":"10.1128\/JVI.00987-06","article-title":"Vaccinia Virus\nG9 Protein Is an Essential\nComponent of the Poxvirus Entry-Fusion Complex","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"8","key":"2026090104121830600_cit83","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1128\/JVI.79.8.4744-4754.2005","article-title":"Vaccinia Virus H2 Protein Is an Essential Component of a Complex\nInvolved in Virus Entry and Cell-Cell Fusion","volume":"79","author":"Senkevich","year":"2005","journal-title":"J. Virol."},{"issue":"12","key":"2026090104121830600_cit84","doi-asserted-by":"publisher","first-page":"e01343","DOI":"10.1128\/jvi.01343-23","article-title":"Structural\nand Functional Analyses\nof Viral H2 Protein of the Vaccinia Virus Entry Fusion Complex","volume":"97","author":"Kao","year":"2023","journal-title":"J. Virol."},{"key":"2026090104121830600_cit85","first-page":"2025.11.13.688282","article-title":"Structure\nand Functional Analyses of Vaccinia Virus Entry-Fusion Complex Component\nJ5 Protein","author":"Chiu","year":"2025","journal-title":"bioRxiv"},{"issue":"17","key":"2026090104121830600_cit86","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.1128\/JVI.79.17.10988-10998.2005","article-title":"The Product of the Vaccinia Virus\nL5R Gene Is a Fourth Membrane Protein Encoded by All Poxviruses That\nIs Required for Cell Entry and Cell-Cell Fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"issue":"19","key":"2026090104121830600_cit87","doi-asserted-by":"publisher","first-page":"9455","DOI":"10.1128\/JVI.01149-06","article-title":"Vaccinia Virus F9 Virion Membrane\nProtein Is Required for Entry but Not Virus Assembly, in Contrast\nto the Related L1 Protein","volume":"80","author":"Brown","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"2026090104121830600_cit88","doi-asserted-by":"publisher","first-page":"16807","DOI":"10.1038\/s41598-018-34244-7","article-title":"The 2.1 \u00c5 Structure\nof Protein F9 and Its Comparison to L1, Two Components of the Conserved\nPoxvirus Entry-Fusion Complex","volume":"8","author":"Diesterbeck","year":"2018","journal-title":"Sci. Rep."},{"issue":"24","key":"2026090104121830600_cit89","doi-asserted-by":"publisher","first-page":"12822","DOI":"10.1128\/JVI.01744-09","article-title":"Characterization of\na Newly Identified 35-Amino-Acid Component of\nthe Vaccinia Virus Entry\/Fusion Complex Conserved in All Chordopoxviruses","volume":"83","author":"Satheshkumar","year":"2009","journal-title":"J. Virol."},{"issue":"3","key":"2026090104121830600_cit90","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1128\/JVI.06069-11","article-title":"Sequence-Divergent\nChordopoxvirus Homologs of the O3 Protein Maintain\nFunctional Interactions with Components of the Vaccinia Virus Entry-Fusion\nComplex","volume":"86","author":"Satheshkumar","year":"2012","journal-title":"J. Virol."},{"issue":"10","key":"2026090104121830600_cit91","doi-asserted-by":"publisher","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia Virus\nEnvelope D8L Protein\nBinds to Cell Surface Chondroitin Sulfate and Mediates the Adsorption\nof Intracellular Mature Virions to Cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J.\nVirol."},{"issue":"1","key":"2026090104121830600_cit92","doi-asserted-by":"publisher","first-page":"19585","DOI":"10.1038\/s41598-024-70433-3","article-title":"Computational Investigations\nof Potential Inhibitors of Monkeypox Virus Envelope Protein E8 through\nMolecular Docking and Molecular Dynamics Simulations","volume":"14","author":"Das","year":"2024","journal-title":"Sci. Rep."},{"issue":"19","key":"2026090104121830600_cit93","doi-asserted-by":"publisher","first-page":"11570","DOI":"10.3390\/ijms231911570","article-title":"Identification\nof Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments\nfor Monkeypox Virus: A Computational Study","volume":"23","author":"Lam","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026090104121830600_cit94","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.M117.814541","article-title":"Structure\u2013Function Characterization of Three\nHuman Antibodies Targeting the Vaccinia Virus Adhesion Molecule D8","volume":"293","author":"Matho","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"2026090104121830600_cit95","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/v14112531","article-title":"A Vaccine Strategy Based on the Identification\nof an Annular Ganglioside Binding Motif in Monkeypox Virus Protein\nE8L","volume":"14","author":"Fantini","year":"2022","journal-title":"Viruses"},{"issue":"15","key":"2026090104121830600_cit96","doi-asserted-by":"publisher","first-page":"8050","DOI":"10.1128\/JVI.00836-12","article-title":"Structural\nand Biochemical Characterization of the Vaccinia Virus Envelope Protein\nD8 and Its Recognition by the Antibody LA5","volume":"86","author":"Matho","year":"2012","journal-title":"J. Virol."},{"issue":"12","key":"2026090104121830600_cit97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004495","article-title":"Murine Anti-Vaccinia Virus D8 Antibodies\nTarget Different Epitopes and Differ in Their Ability to Block D8\nBinding to CS-E","volume":"10","author":"Matho","year":"2014","journal-title":"PLoS Pathog."},{"issue":"5","key":"2026090104121830600_cit98","doi-asserted-by":"publisher","first-page":"e01598","DOI":"10.1128\/spectrum.01598-23","article-title":"Generation of Recombinant\nmAbs to Vaccinia Virus Displaying High Affinity and Potent Neutralization","volume":"11","author":"Noy-Porat","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"2026090104121830600_cit99","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/vaccines13050471","article-title":"Isolation and Characterization\nof E8Monoclonal Antibodies\nfrom Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient\nNeutralization of Authentic Monkeypox Virus","volume":"13","author":"Shi","year":"2025","journal-title":"Vaccines"},{"issue":"3","key":"2026090104121830600_cit377","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing\nand Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"issue":"8","key":"2026090104121830600_cit100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003563","article-title":"Crystal Structure of\nVaccinia Viral A27 Protein Reveals a Novel Structure Critical for\nIts Function and Complex Formation with A26 Protein","volume":"9","author":"Chang","year":"2013","journal-title":"PLoS Pathog."},{"issue":"5","key":"2026090104121830600_cit101","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/md21050264","article-title":"SPR Sensor-Based Analysis\nof the Inhibition\nof Marine Sulfated Glycans on Interactions between Monkeypox Virus\nProteins and Glycosaminoglycans","volume":"21","author":"He","year":"2023","journal-title":"Mar. Drugs"},{"issue":"18","key":"2026090104121830600_cit102","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.3390\/molecules27185898","article-title":"Kinetic and Structural\nAspects of Glycosaminoglycan\u2013Monkeypox Virus Protein A29 Interactions\nUsing Surface Plasmon Resonance","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"2026090104121830600_cit103","doi-asserted-by":"publisher","first-page":"2223669","DOI":"10.1080\/22221751.2023.2223669","article-title":"Three\nNeutralizing mAbs Induced by MPXV A29L Protein Recognizing\nDifferent Epitopes Act Synergistically against Orthopoxvirus","volume":"12","author":"Li","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"2026090104121830600_cit104","doi-asserted-by":"publisher","first-page":"e02320","DOI":"10.1128\/jvi.02320-24","article-title":"Bispecific\nAntibodies Targeting MPXV A29 and B6 Demonstrate Efficacy against\nMPXV Infection","volume":"99","author":"Li","year":"2025","journal-title":"J. Virol."},{"issue":"16","key":"2026090104121830600_cit105","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.1128\/JVI.74.16.7518-7528.2000","article-title":"Effects of\nDeletion or Stringent Repression of the H3L Envelope Gene on Vaccinia\nVirus Replication","volume":"74","author":"da Fonseca","year":"2000","journal-title":"J. Virol."},{"issue":"18","key":"2026090104121830600_cit106","doi-asserted-by":"publisher","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia Virus\nH3L Envelope Protein\nIs a Major Target of Neutralizing Antibodies in Humans and Elicits\nProtection against Lethal Challenge in Mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"2026090104121830600_cit107","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1128\/JVI.02933-15","article-title":"The Vaccinia Virus\nH3 Envelope Protein,\na Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase\nFold and Binds UDP-Glucose","volume":"90","author":"Singh","year":"2016","journal-title":"J. Virol."},{"key":"2026090104121830600_cit108","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.100545","article-title":"Discovery\nof a heparan sulfate binding domain in monkeypox virus\nH3 as an anti-poxviral drug target combining AI and MD simulations","volume":"13","author":"Zheng","year":"2025","journal-title":"eLife"},{"key":"2026090104121830600_cit109","doi-asserted-by":"publisher","first-page":"1073419","DOI":"10.3389\/fmicb.2022.1073419","article-title":"Targeting\nEnvelope Proteins of Poxviruses to Repurpose Phytochemicals against\nMonkeypox: An in Silico Investigation","volume":"13","author":"Gulati","year":"2023","journal-title":"Front.\nMicrobiol."},{"issue":"5","key":"2026090104121830600_cit110","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s12026-024-09499-0","article-title":"Analysis of Binding\nand Authentic Virus-Neutralizing Activities of Immune Sera Induced\nby Various Monkeypox Virus Antigens","volume":"72","author":"Song","year":"2024","journal-title":"Immunol.\nRes."},{"issue":"1","key":"2026090104121830600_cit111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00253-025-13466-6","article-title":"Monkeypox Virus H3L Protein as the\nTarget Antigen for Developing Neutralizing Antibody and Serological\nAssay","volume":"109","author":"Huang","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"2026090104121830600_cit112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66344-0","article-title":"Potent Neutralization by Antibodies Targeting the MPXV A28 Protein","author":"Yefet","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"2026090104121830600_cit113","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1128\/JVI.06081-11","article-title":"Vaccinia Mature\nVirus Fusion Regulator A26 Protein Binds to A16 and G9 Proteins of\nthe Viral Entry Fusion Complex and Dissociates from Mature Virions\nat Low pH","volume":"86","author":"Chang","year":"2012","journal-title":"J. Virol."},{"issue":"24","key":"2026090104121830600_cit114","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.1128\/JVI.01524-08","article-title":"Vaccinia Virus A26\nand A27 Proteins Form a Stable Complex Tethered to Mature Virions\nby Association with the A17 Transmembrane Protein","volume":"82","author":"Howard","year":"2008","journal-title":"J. Virol."},{"key":"2026090104121830600_cit115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aeb3840","article-title":"Antigen-Agnostic Identification of Poxvirus Broadly Neutralizing\nAntibodies Targeting OPG153","author":"Paciello","year":"2025","journal-title":"Sci. Transl Med."},{"issue":"12","key":"2026090104121830600_cit116","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.0501103102","article-title":"The 1.51-\u00c5\nStructure of the\nPoxvirus L1 Protein, a Target of Potent Neutralizing Antibodies","volume":"102","author":"Su","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"2026090104121830600_cit117","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1128\/JVI.06703-11","article-title":"The Myristate\nMoiety and Amino Terminus of Vaccinia Virus L1 Constitute a Bipartite\nFunctional Region Needed for Entry","volume":"86","author":"Foo","year":"2012","journal-title":"J. Virol."},{"issue":"2","key":"2026090104121830600_cit118","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural Basis\nfor the Binding of the Neutralizing\nAntibody, 7D11, to the Poxvirus L1 Protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"issue":"19","key":"2026090104121830600_cit119","doi-asserted-by":"publisher","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent Neutralization of Vaccinia Virus by Divergent\nMurine Antibodies Targeting a Common Site of Vulnerability in L1 Protein","volume":"88","author":"Kaever","year":"2014","journal-title":"J. Virol."},{"issue":"10","key":"2026090104121830600_cit120","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1038\/s44321-025-00299-z","article-title":"Anti-M1R\/B6R Antibody Characterization and\nBispecific\nDesign for Enhanced Orthopoxvirus Protection","volume":"17","author":"Zhao","year":"2025","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"2026090104121830600_cit121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-025-00771-7","article-title":"Identification of Neutralizing\nNanobodies Protecting\nagainst Poxvirus Infection","volume":"11","author":"Yang","year":"2025","journal-title":"Cell Discovery"},{"issue":"1","key":"2026090104121830600_cit122","doi-asserted-by":"publisher","first-page":"2401931","DOI":"10.1080\/22221751.2024.2401931","article-title":"Identification of mpox\nM1R and B6R monoclonal and bispecific antibodies\nthat efficiently neutralize authentic mpox virus","volume":"13","author":"Ren","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"2026090104121830600_cit123","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1038\/s41467-025-58180-z","article-title":"Generation\nand Characterization of Neutralizing Antibodies against M1R and B6R\nProteins of Monkeypox Virus","volume":"16","author":"Qu","year":"2025","journal-title":"Nat. Commun."},{"issue":"10","key":"2026090104121830600_cit124","doi-asserted-by":"publisher","first-page":"e00077","DOI":"10.1128\/JVI.00077-20","article-title":"Mutations Near the\nN Terminus of\nVaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and\nSyncytium Formation Imposed by the A56\/K2 Fusion Regulatory Complex","volume":"94","author":"Cotter","year":"2020","journal-title":"J. Virol."},{"issue":"11","key":"2026090104121830600_cit125","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1128\/JVI.00162-08","article-title":"Vaccinia Virus\nA56\/K2\nFusion Regulatory Protein Interacts with the A16 and G9 Subunits of\nthe Entry Fusion Complex","volume":"82","author":"Wagenaar","year":"2008","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit126","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1016\/j.ymthe.2024.06.038","article-title":"Discovery\nof a Novel Inhibitor of Macropinocytosis with Antiviral Activity","volume":"32","author":"Porebski","year":"2024","journal-title":"Mol. Ther."},{"issue":"3","key":"2026090104121830600_cit127","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1128\/JVI.79.3.1623-1634.2005","article-title":"Vaccinia Virus\nPenetration\nRequires Cholesterol and Results in Specific Viral Envelope Proteins\nAssociated with Lipid Rafts","volume":"79","author":"Chung","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"2026090104121830600_cit128","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2413","article-title":"Viral Modulation\nof Lipid Rafts and Their Potential as Putative Antiviral Targets","volume":"33","author":"Gee","year":"2023","journal-title":"Rev. Med. Virol."},{"issue":"10","key":"2026090104121830600_cit129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010662","article-title":"Inhibition of Vaccinia\nVirus L1 N-Myristoylation by the Host N-Myristoyltransferase Inhibitor\nIMP-1088 Generates Non-Infectious Virions Defective in Cell Entry","volume":"18","author":"Priyamvada","year":"2022","journal-title":"PLOS Pathog."},{"issue":"23","key":"2026090104121830600_cit130","doi-asserted-by":"publisher","first-page":"9790","DOI":"10.1021\/acs.jmedchem.7b01255","article-title":"Design\nand Synthesis of Brain Penetrant Trypanocidal N -Myristoyltransferase\nInhibitors","volume":"60","author":"Bayliss","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090104121830600_cit131","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/v17010092","article-title":"Repurposing Drugs for Synergistic\nCombination Therapies\nto Counteract Monkeypox Virus Tecovirimat Resistance","volume":"17","author":"Witwit","year":"2025","journal-title":"Viruses"},{"issue":"6627","key":"2026090104121830600_cit132","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.ade6360","article-title":"Structure of Monkeypox Virus DNA\nPolymerase Holoenzyme","volume":"379","author":"Peng","year":"2023","journal-title":"Science"},{"issue":"49","key":"2026090104121830600_cit133","doi-asserted-by":"publisher","first-page":"31190","DOI":"10.1016\/S0021-9258(18)47408-X","article-title":"Vaccinia Virus DNA Polymerase. In\nVitro Analysis of Parameters Affecting Processivity","volume":"269","author":"McDonald","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"23","key":"2026090104121830600_cit134","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.molcel.2023.10.038","article-title":"Structural\nInsights into the Assembly and Mechanism of Mpox Virus DNA Polymerase\nComplex F8-A22-E4-H5","volume":"83","author":"Wang","year":"2023","journal-title":"Mol. Cell"},{"issue":"10","key":"2026090104121830600_cit135","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1128\/jvi.70.10.6796-6802.1996","article-title":"The Vaccinia Virus H5R Gene Encodes\nLate Gene Transcription Factor 4: Purification, Cloning, and Overexpression","volume":"70","author":"Kovacs","year":"1996","journal-title":"J. Virol."},{"issue":"10","key":"2026090104121830600_cit136","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2411686122","article-title":"Structural\nBasis of DNA Replication Fidelity of the Mpox Virus","volume":"122","author":"Xie","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026090104121830600_cit137","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41467-017-01542-z","article-title":"The Vaccinia Virus DNA Polymerase\nStructure Provides Insights into the Mode of Processivity Factor Binding","volume":"8","author":"Tarbouriech","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"2026090104121830600_cit138","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1128\/AAC.46.5.1329-1335.2002","article-title":"Characterization of Wild-Type and Cidofovir-Resistant\nStrains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses","volume":"46","author":"Smee","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"2026090104121830600_cit139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the Treatment of Poxvirus\nInfections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"issue":"4","key":"2026090104121830600_cit140","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous Cidofovir\nfor Peripheral Cytomegalovirus Retinitis in Patients with AIDS: A\nRandomized, Controlled Trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann. Int. Med."},{"issue":"2","key":"2026090104121830600_cit141","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/AAC.01172-07","article-title":"Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine\nAre Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When\nIncorporated into the Template Strand","volume":"52","author":"Magee","year":"2008","journal-title":"Antimicrob.\nAgents Chemother."},{"issue":"1","key":"2026090104121830600_cit142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0042-6822(90)90271-R","article-title":"Selective Inhibition of Human Cytomegalovirus DNA Synthesis\nby (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine [(S)-HPMPC]\nand 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine (DHPG)","volume":"179","author":"Neyts","year":"1990","journal-title":"Virology"},{"issue":"6","key":"2026090104121830600_cit143","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/14728222.2023.2230361","article-title":"Potential\nTherapeutic Targets for Mpox: The Evidence to Date","volume":"27","author":"Byrareddy","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"2026090104121830600_cit144","doi-asserted-by":"publisher","first-page":"132231","DOI":"10.1016\/j.ijbiomac.2024.132231","article-title":"Structural\nBasis of Human Mpox Viral DNA Replication Inhibition by Brincidofovir\nand Cidofovir","volume":"270","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"2026090104121830600_cit145","doi-asserted-by":"publisher","first-page":"105995","DOI":"10.1016\/j.antiviral.2024.105995","article-title":"Treatment Efficacy of Cidofovir and Brincidofovir against\nClade II Monkeypox Virus Isolates","volume":"231","author":"Pre\u0301vost","year":"2024","journal-title":"Antiviral\nRes."},{"key":"2026090104121830600_cit146","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10112192","volume-title":"Animal Models\nUsed in\nMonkeypox Research","author":"Doma\u0301n","year":"2022"},{"issue":"1","key":"2026090104121830600_cit147","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir Protects Mice against Lethal\nAerosol or Intranasal Cowpox Virus Challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"3","key":"2026090104121830600_cit148","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/095632020801900302","article-title":"Progress\nin the Discovery of Compounds Inhibiting Orthopoxviruses\nin Animal Models","volume":"19","author":"Smee","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"issue":"2","key":"2026090104121830600_cit149","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1128\/JVI.00984-08","article-title":"Coadministration of Cidofovir and Smallpox Vaccine\nReduced Vaccination Side Effects but Interfered with Vaccine-Elicited\nImmune Responses and Immunity to Monkeypox","volume":"83","author":"Wei","year":"2009","journal-title":"J. Virol."},{"issue":"12","key":"2026090104121830600_cit150","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir Activity against Poxvirus\nInfections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"issue":"1","key":"2026090104121830600_cit151","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28218","article-title":"Real-life\nUse of Cidofovir for the Treatment of Severe Monkeypox Cases","volume":"95","author":"Raccagni","year":"2023","journal-title":"J. Med. Virol."},{"issue":"2","key":"2026090104121830600_cit152","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/biomedicines11020278","article-title":"Oral Brincidofovir Therapy for Monkeypox Outbreak:\nA Focused Review on the Therapeutic Potential, Clinical Studies, Patent\nLiterature, and Prospects","volume":"11","author":"Imran","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"2026090104121830600_cit153","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification\nof Cidofovir with Alkoxyalkanols Increases Oral Bioavailability and\nDiminishes Drug Accumulation in Kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral\nRes."},{"key":"2026090104121830600_cit154","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","article-title":"Short-Term\nClinical Safety Profile of Brincidofovir: A Favorable Benefit\u2013Risk\nProposition in the Treatment of Smallpox","volume":"143","author":"Chittick","year":"2017","journal-title":"Antiviral\nRes."},{"issue":"1","key":"2026090104121830600_cit155","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy\nof Therapeutic Intervention with an Oral Ether\u2013Lipid\nAnalogue of Cidofovir (CMX001) in a Lethal Mousepox Model","volume":"77","author":"Parker","year":"2008","journal-title":"Antiviral Res."},{"issue":"1","key":"2026090104121830600_cit156","doi-asserted-by":"publisher","first-page":"e00927","DOI":"10.1128\/mSphere.00927-20","article-title":"Pharmacokinetics\nand Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in\na Lethal Monkeypox Virus Animal Model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"2026090104121830600_cit157","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2015.02.007","article-title":"The Efficacy and\nPharmacokinetics of Brincidofovir for the Treatment of Lethal Rabbitpox\nVirus Infection: A Model of Smallpox Disease","volume":"117","author":"Trost","year":"2015","journal-title":"Antiviral Res."},{"key":"2026090104121830600_cit158","volume-title":"Product Development under the Animal Rule Guidance\nfor Industry","year":"2015"},{"issue":"2","key":"2026090104121830600_cit159","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A Randomized, Double-Blind,\nPlacebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus\nProphylaxis in Allogeneic Hematopoietic Cell Transplantation","volume":"25","author":"Marty","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"13","key":"2026090104121830600_cit160","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001\nto Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"2026090104121830600_cit161","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical\nFeatures and\nManagement of Human Monkeypox: A Retrospective Observational Study\nin the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"2026090104121830600_cit162","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1021\/acs.jmedchem.3c00069","article-title":"An Overview of Antivirals against Monkeypox Virus and\nOther Orthopoxviruses","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026090104121830600_cit163","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/med.21943","article-title":"Human Mpox: Biology, Epidemiology,\nTherapeutic Options, and Development of Small Molecule Inhibitors","volume":"43","author":"Tang","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"11","key":"2026090104121830600_cit164","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70669","article-title":"Monkeypox Virus Is Inhibited\nby Nucleoside Analogues Including the Acyclic Phosphonates Adefovir\nand Tenofovir In Vitro","volume":"97","author":"Lee","year":"2025","journal-title":"J. Med. Virol."},{"key":"2026090104121830600_cit165","doi-asserted-by":"publisher","first-page":"105651","DOI":"10.1016\/j.antiviral.2023.105651","article-title":"Antiviral\nActivities of Two Nucleos(t)Ide Analogs against Vaccinia, Mpox, and\nCowpox Viruses in Primary Human Fibroblasts","volume":"216","author":"Dsouza","year":"2023","journal-title":"Antiviral Res."},{"issue":"1","key":"2026090104121830600_cit166","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29354","article-title":"Trifluridine\nfor Treatment of Mpox Infection in Drug Combinations in Ophthalmic\nCell Models","volume":"96","author":"Cinatl","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"2026090104121830600_cit167","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41392-025-02207-w","article-title":"Novel Derivatives of Brincidofovir and (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine\nInhibit Orthopoxviruses and Human Adenoviruses More Potently than\nBrincidofovir","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"22","key":"2026090104121830600_cit168","doi-asserted-by":"publisher","first-page":"23867","DOI":"10.1021\/acs.jmedchem.5c00863","article-title":"Lipid-Optimized Sulfone-Bridged Cidofovir Prodrugs\nas Potent Antivirals Against Orthopoxviruses","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6","key":"2026090104121830600_cit376","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/acsinfecdis.5c00169","article-title":"Antiviral Activity of the Acyclic\nNucleoside Phosphonate\nProdrug LAVR-289 against Poxviruses and African Swine Fever Virus","volume":"11","author":"Marcheteau","year":"2025","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"2026090104121830600_cit169","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/s42003-025-09129-x","article-title":"AI-Driven Discovery\nof Antiretroviral Drug Bictegravir and Etravirine as Inhibitors against\nMonkeypox and Related Poxviruses","volume":"8","author":"Wang","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"2026090104121830600_cit170","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1472-6807-7-45","article-title":"Crystal Structure\nof Vaccinia Virus\nUracil-DNA Glycosylase Reveals Dimeric Assembly","volume":"7","author":"Schormann","year":"2007","journal-title":"BMC Struct. Biol."},{"issue":"1","key":"2026090104121830600_cit171","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1128\/JVI.77.1.159-166.2003","article-title":"Vaccinia Virus Uracil DNA Glycosylase\nHas an Essential Role in DNA Synthesis That Is Independent of Its\nGlycosylase Activity: Catalytic Site Mutations Reduce Virulence but\nNot Virus Replication in Cultured Cells","volume":"77","author":"De Silva","year":"2003","journal-title":"J.\nVirol."},{"issue":"2","key":"2026090104121830600_cit172","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0959-440X(02)00313-5","article-title":"Clamp Loaders and Sliding\nClamps","volume":"12","author":"Jeruzalmi","year":"2002","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6","key":"2026090104121830600_cit173","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.str.2024.03.004","article-title":"Structural\nBasis for\nthe Inhibition Mechanism of the DNA Polymerase Holoenzyme from Mpox\nVirus","volume":"32","author":"Shen","year":"2024","journal-title":"Structure"},{"issue":"53","key":"2026090104121830600_cit174","doi-asserted-by":"publisher","first-page":"27087","DOI":"10.1074\/jbc.M116.761908","article-title":"A Conserved\nTripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity\nFactor D4 Is Essential for Protein Integrity and Function","volume":"291","author":"Nuth","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2026090104121830600_cit175","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2018.12.011","volume-title":"Mutation and Structure\nGuided Discovery of an Antiviral Small Molecule That Mimics an Essential\nC-Terminal Tripeptide of the Vaccinia D4 Processivity Factor","author":"Nuth","year":"2019"},{"issue":"3","key":"2026090104121830600_cit176","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.antiviral.2009.02.191","article-title":"Inhibition\nof Vaccinia Virus Replication\nby Peptide Aptamers","volume":"82","author":"Saccucci","year":"2009","journal-title":"Antiviral Res."},{"issue":"9","key":"2026090104121830600_cit177","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1021\/jm101554k","article-title":"Identification\nof Inhibitors That\nBlock Vaccinia Virus Infection by Targeting the DNA Synthesis Processivity\nFactor D4","volume":"54","author":"Nuth","year":"2011","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026090104121830600_cit178","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1128\/AAC.00278-11","article-title":"Identification of Protein-Protein Interaction Inhibitors\nTargeting Vaccinia Virus Processivity Factor for Development of Antiviral\nAgents","volume":"55","author":"Schormann","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"2026090104121830600_cit179","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1128\/JVI.01533-12","article-title":"Low-Resolution\nStructure of Vaccinia Virus DNA Replication Machinery","volume":"87","author":"Se\u0300le","year":"2013","journal-title":"J. Virol."},{"issue":"8","key":"2026090104121830600_cit180","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1021\/jm301735k","article-title":"Design of Potent Poxvirus Inhibitors\nof the Heterodimeric Processivity Factor Required for Viral Replication","volume":"56","author":"Nuth","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026090104121830600_cit181","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.antiviral.2012.07.010","article-title":"A Small Molecule Screen\nin Yeast Identifies Inhibitors Targeting Protein\u2013Protein Interactions\nwithin the Vaccinia Virus Replication Complex","volume":"96","author":"Flusin","year":"2012","journal-title":"Antiviral Res."},{"issue":"3","key":"2026090104121830600_cit182","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0022-2836(88)90613-4","article-title":"Molecular\nCloning and\nSequence of the Concatemer Junction from Vaccinia Virus Replicative\nDNA","volume":"199","author":"Merchlinsky","year":"1988","journal-title":"J. Mol. Biol."},{"issue":"2","key":"2026090104121830600_cit183","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.virol.2006.05.007","article-title":"DNA Cleavage\nby the A22R Resolvase of Vaccinia Virus","volume":"352","author":"Culyba","year":"2006","journal-title":"Virology"},{"issue":"14","key":"2026090104121830600_cit184","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1128\/JVI.75.14.6460-6471.2001","article-title":"Repression of Vaccinia Virus Holliday\nJunction Resolvase Inhibits Processing of Viral DNA into Unit-Length\nGenomes","volume":"75","author":"Garcia","year":"2001","journal-title":"J. Virol."},{"issue":"16","key":"2026090104121830600_cit185","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.1073\/pnas.150238697","article-title":"Bacterial-Type\nDNA Holliday Junction Resolvases in Eukaryotic Viruses","volume":"97","author":"Garcia","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"2026090104121830600_cit186","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/sj.emboj.7601076","article-title":"Stepwise Analyses of\nMetal Ions in\nRNase H Catalysis from Substrate Destabilization to Product Release","volume":"25","author":"Nowotny","year":"2006","journal-title":"EMBO J."},{"issue":"7","key":"2026090104121830600_cit187","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.cell.2005.04.024","article-title":"Crystal Structures\nof RNase H Bound to an RNA\/DNA Hybrid: Substrate Specificity and Metal-Dependent\nCatalysis","volume":"121","author":"Nowotny","year":"2005","journal-title":"Cell"},{"issue":"21","key":"2026090104121830600_cit188","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1074\/jbc.M115.709139","article-title":"Structure\nand Metal Binding Properties of a Poxvirus Resolvase","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"16","key":"2026090104121830600_cit189","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1093\/nar\/gks325","article-title":"Bulged DNA Substrates\nfor Identifying\nPoxvirus Resolvase Inhibitors","volume":"40","author":"Culyba","year":"2012","journal-title":"Nucleic Acids\nRes."},{"key":"2026090104121830600_cit190","doi-asserted-by":"publisher","first-page":"acs.jmedchem.5c03356","DOI":"10.1021\/acs.jmedchem.5c03356","article-title":"1-Hydroxy-1,8-Napthyridinone\n(DHN) Analogs Potently Inhibit Monkeypox\nVirus Resolvase (Mpr)","author":"Offei","year":"2025","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026090104121830600_cit191","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/jvi.38.2.606-611.1981","article-title":"Phosphorylation of Acyclovir [9-(2-Hydroxyethoxymethyl)Guanine]\nin Epstein-Barr Virus-Infected Lymphoblastoid Cell Lines","volume":"38","author":"Colby","year":"1981","journal-title":"J. Virol."},{"issue":"1","key":"2026090104121830600_cit192","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-6807-6-22","article-title":"Structure of Vaccinia Virus Thymidine Kinase in Complex\nwith dTTP: Insights for Drug Design","volume":"6","author":"El Omari","year":"2006","journal-title":"BMC Struct.\nBiol."},{"key":"2026090104121830600_cit193","doi-asserted-by":"publisher","first-page":"106125","DOI":"10.1016\/j.antiviral.2025.106125","article-title":"Structural and Mechanistic\nInsight into the Phosphorylation Reaction Catalyzed by Mpox Virus\nThymidine Kinase","volume":"237","author":"Zhang","year":"2025","journal-title":"Antiviral Res."},{"issue":"1","key":"2026090104121830600_cit194","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1099\/0022-1317-72-1-125","article-title":"Comparison\nof the Virulence of Wild-Type Thymidine Kinase (Tk)-Deficient and\nTk+ Phenotypes of Vaccinia Virus Recombinants after Intranasal Inoculation\nof Mice","volume":"72","author":"Taylor","year":"1991","journal-title":"J. Gen. Virol."},{"issue":"1","key":"2026090104121830600_cit195","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2006.04.010","article-title":"Cell Line Dependency\nfor Antiviral Activity and in Vivo Efficacy of N-Methanocarbathymidine\nagainst Orthopoxvirus Infections in Mice","volume":"73","author":"Smee","year":"2007","journal-title":"Antiviral\nRes."},{"issue":"2\u20133","key":"2026090104121830600_cit196","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.antiviral.2006.04.012","article-title":"The History\nof N-Methanocarbathymidine: The Investigation of a Conformational\nConcept Leads to the Discovery of a Potent and Selective Nucleoside\nAntiviral Agent","volume":"71","author":"Marquez","year":"2006","journal-title":"Antiviral Res."},{"issue":"4","key":"2026090104121830600_cit197","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1128\/AAC.50.4.1336-1341.2006","article-title":"Activity\nand Mechanism of Action of N -Methanocarbathymidine\nagainst Herpesvirus and Orthopoxvirus Infections","volume":"50","author":"Prichard","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"2026090104121830600_cit198","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.antiviral.2007.06.005","article-title":"Efficacy of N-Methanocarbathymidine\nin Treating Mice Infected Intranasally with the IHD and WR Strains\nof Vaccinia Virus","volume":"76","author":"Smee","year":"2007","journal-title":"Antiviral Res."},{"issue":"2","key":"2026090104121830600_cit199","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1021\/ja037929e","article-title":"Experimental\nand Structural Evidence\nThat Herpes 1 Kinase and Cellular DNA Polymerase(s) Discriminate on\nthe Basis of Sugar Pucker","volume":"126","author":"Marquez","year":"2004","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"2026090104121830600_cit200","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1128\/AAC.01257-08","article-title":"Activities\nof Certain\n5-Substituted 4\u2032-Thiopyrimidine Nucleosides against Orthopoxvirus\nInfections","volume":"53","author":"Kern","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"2026090104121830600_cit201","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1021\/jm060404n","article-title":"Toward Orthopoxvirus Countermeasures:\nA Novel Heteromorphic Nucleoside of Unusual Structure","volume":"49","author":"Fan","year":"2006","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026090104121830600_cit202","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s11030-023-10692-w","article-title":"Identification of Novel Potential\nInhibitors of Monkeypox\nVirus Thymidine Kinase Using Molecular Docking, Molecular Dynamics\nSimulation and MM\/PBSA Methods","volume":"28","author":"Abdizadeh","year":"2024","journal-title":"Mol. Divers."},{"issue":"10","key":"2026090104121830600_cit203","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1080\/07391102.2013.830578","article-title":"Preventing\nthe Return of Smallpox: Molecular Modeling Studies on Thymidylate\nKinase from Variola Virus","volume":"32","author":"Guimara\u0303es","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"24","key":"2026090104121830600_cit204","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1111\/j.1742-4658.2005.05006.x","article-title":"Substrate\nSpecificity of Vaccinia Virus Thymidylate Kinase","volume":"272","author":"Topalis","year":"2005","journal-title":"FEBS J."},{"issue":"10","key":"2026090104121830600_cit205","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2174\/0929867311320100006","article-title":"Thymidylate Kinase:\nAn Old Topic Brings New Perspectives","volume":"20","author":"Cui","year":"2013","journal-title":"Curr.\nMed. Chem."},{"issue":"6","key":"2026090104121830600_cit206","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1073\/pnas.0711573105","article-title":"Kinetic Analysis of a Complete Poxvirus Transcriptome\nReveals an Immediate-Early Class of Genes","volume":"105","author":"Assarsson","year":"2008","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"issue":"44","key":"2026090104121830600_cit207","doi-asserted-by":"publisher","first-page":"16900","DOI":"10.1073\/pnas.0804525105","article-title":"Crystal Structure of Poxvirus Thymidylate Kinase: An Unexpected Dimerization\nHas Implications for Antiviral Therapy","volume":"105","author":"Caillat","year":"2008","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"key":"2026090104121830600_cit208","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejmech.2014.09.099","article-title":"Design\nof Inhibitors of Thymidylate Kinase from Variola Virus as New Selective\nDrugs against Smallpox","volume":"91","author":"Guimara\u0303es","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"2026090104121830600_cit209","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1080\/07391102.2018.1554510","article-title":"Design of\nInhibitors of Thymidylate Kinase from Variola Virus as New Selective Drugs against Smallpox: Part II","volume":"37","author":"Rodrigues Garcia","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"2026090104121830600_cit210","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/ph14101027","article-title":"In Silico Studies of Potential Selective Inhibitors\nof Thymidylate Kinase from Variola Virus","volume":"14","author":"Garcia","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026090104121830600_cit211","doi-asserted-by":"publisher","first-page":"106797","DOI":"10.1016\/j.compbiomed.2023.106797","article-title":"Structure-Based\nDesign of Promising\nNatural Products to Inhibit Thymidylate Kinase from Monkeypox Virus\nand Validation Using Free Energy Calculations","volume":"158","author":"Khan","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"5","key":"2026090104121830600_cit212","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s11030-023-10764-x","article-title":"Identification of the\nMyxobacterial Secondary Metabolites Aurachin A and Soraphinol A as\nPromising Inhibitors of Thymidylate Kinase of the Monkeypox Virus","volume":"28","author":"Ali","year":"2024","journal-title":"Mol. Divers."},{"key":"2026090104121830600_cit213","volume-title":"IMP Dehydrogenase: Structure,\nMechanism, and Inhibition","author":"Hedstrom"},{"issue":"1\u20132","key":"2026090104121830600_cit214","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential Antiviral\nTherapeutics for Smallpox, Monkeypox and Other Orthopoxvirus Infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"issue":"3","key":"2026090104121830600_cit215","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2217\/fvl-2018-0166","article-title":"Ribavirin:\nPharmacology, Multiple Modes of Action and Possible Future Perspectives","volume":"14","author":"Nystro\u0308m","year":"2019","journal-title":"Future Virol."},{"issue":"2","key":"2026090104121830600_cit216","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1099\/0022-1317-32-2-327","article-title":"Inhibition of Vaccinia\nVirus Growth by the Nucleoside Analogue 1-Beta-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide\n(Virazole, Ribavirin)","volume":"32","author":"Katz","year":"1976","journal-title":"J. Gen. Virol."},{"issue":"3","key":"2026090104121830600_cit217","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3181\/00379727-151-39241","article-title":"Effect of Cytosine Arabinoside, Lododeoxyuridine,\nEthyldeoxyuridine, Thiocyanatodeoxyuridine, and Ribavirin on Tail\nLesion Formation in Mice Infected with Vaccinia Virus","volume":"151","author":"Clercq","year":"1976","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"2026090104121830600_cit218","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0166-3542(00)00105-4","article-title":"Intranasal\nTreatment of Cowpox Virus Respiratory Infections in Mice with Cidofovir","volume":"47","author":"Smee","year":"2000","journal-title":"Antiviral Res."},{"key":"2026090104121830600_cit219","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/095632020001100406","article-title":"Treatment\nof Cowpox\nVirus Respiratory Infections in Mice with Ribavirin as a Single Agent\nor Followed Sequentially by Cidofovir","volume":"11","author":"Smee","year":"2000","journal-title":"Antivir.\nChem. Chemother."},{"issue":"3","key":"2026090104121830600_cit220","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.antiviral.2006.10.007","article-title":"Antiviral Activity\nof Tiazofurin and Mycophenolic Acid against Grapevine Leafroll-Associated\nVirus 3 in Vitis Vinifera Explants","volume":"73","author":"Panattoni","year":"2007","journal-title":"Antiviral\nRes."},{"issue":"4","key":"2026090104121830600_cit221","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1128\/AAC.35.4.679","article-title":"Antiviral Activities\nof 5-Ethynyl-1-Beta-D-Ribofuranosylimidazole-4- Carboxamide and Related\nCompounds","volume":"35","author":"De Clercq","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"2026090104121830600_cit222","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/095632020101200602","article-title":"Antiviral Activity\nand Mode of Action Studies of Ribavirin and Mycophenolic Acid against\nOrthopoxviruses in Vitro","volume":"12","author":"Smee","year":"2001","journal-title":"Antivir.\nChem. Chemother."},{"issue":"4","key":"2026090104121830600_cit223","doi-asserted-by":"publisher","first-page":"e04745","DOI":"10.1128\/spectrum.04745-22","article-title":"Identification of In Vitro Inhibitors of Monkeypox Replication","volume":"11","author":"Chiem","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"18","key":"2026090104121830600_cit224","doi-asserted-by":"publisher","first-page":"e00838","DOI":"10.1128\/JVI.00838-17","article-title":"Inhibition\nof Poxvirus Gene Expression\nand Genome Replication by Bisbenzimide Derivatives","volume":"91","author":"Yakimovich","year":"2017","journal-title":"J. Virol."},{"issue":"4","key":"2026090104121830600_cit225","doi-asserted-by":"publisher","first-page":"e04072","DOI":"10.1128\/spectrum.04072-23","article-title":"Bisbenzimide Compounds\nInhibit the Replication of Prototype\nand Pandemic Potential Poxviruses","volume":"12","author":"Samolej","year":"2024","journal-title":"Microbiol.\nSpectr."},{"issue":"3","key":"2026090104121830600_cit226","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4062\/biomolther.2021.032","article-title":"Antiviral\nEfficacy of Pralatrexate against SARS-CoV-2","volume":"29","author":"Bae","year":"2021","journal-title":"Biomol. Ther."},{"key":"2026090104121830600_cit227","doi-asserted-by":"publisher","first-page":"105787","DOI":"10.1016\/j.antiviral.2023.105787","article-title":"Pralatrexate Inhibited the Replication of Varicella\nZoster Virus\nand Vesicular Stomatitis Virus: An Old Dog with New Tricks","volume":"221","author":"Wu","year":"2024","journal-title":"Antiviral Res."},{"key":"2026090104121830600_cit228","doi-asserted-by":"publisher","first-page":"106232","DOI":"10.1016\/j.antiviral.2025.106232","article-title":"Pralatrexate Effectively\nInhibits the Replication of Monkeypox Virus in Vitro and in Vivo","volume":"241","author":"Li","year":"2025","journal-title":"Antiviral Res."},{"issue":"6","key":"2026090104121830600_cit229","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1128\/jvi.61.6.1765-1771.1987","article-title":"DNA-Dependent RNA Polymerase\nSubunits Encoded within the Vaccinia Virus Genome","volume":"61","author":"Jones","year":"1987","journal-title":"J. Virol."},{"issue":"7","key":"2026090104121830600_cit230","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cell.2019.11.023","article-title":"Structural\nBasis of Poxvirus Transcription: Transcribing and Capping Vaccinia\nComplexes","volume":"179","author":"Hillen","year":"2019","journal-title":"Cell"},{"issue":"2","key":"2026090104121830600_cit231","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11262-008-0207-3","article-title":"Expansion of Poxvirus\nRNA Polymerase\nSubunits Sharing Homology with Corresponding Subunits of RNA Polymerase\nII","volume":"36","author":"Knutson","year":"2008","journal-title":"Virus Genes"},{"issue":"4","key":"2026090104121830600_cit375","doi-asserted-by":"publisher","first-page":"e03586-23","DOI":"10.1128\/spectrum.03586-23","article-title":"Orally Available\nNucleoside Analog UMM-766 Provides Protection in a Murine Model of\nOrthopox Disease","volume":"12","author":"Mudhasani","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"2026090104121830600_cit374","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/JVI.05416-11","article-title":"Identification of a Pyridopyrimidinone\nInhibitor of\nOrthopoxviruses from a Diversity-Oriented Synthesis Library","volume":"86","author":"Dower","year":"2012","journal-title":"J. Virol."},{"issue":"11","key":"2026090104121830600_cit373","doi-asserted-by":"publisher","first-page":"e00841-22","DOI":"10.1128\/aac.00841-22","article-title":"Identification of Small Molecules\nwith Improved Potency\nagainst Orthopoxviruses from Vaccinia to Smallpox","volume":"66","author":"Brown","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"2026090104121830600_cit232","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jiph.2023.04.019","article-title":"Exploration\nof Natural\nCompounds against the Human Mpox Virus DNA-Dependent RNA Polymerase\nin Silico","volume":"16","author":"Abduljalil","year":"2023","journal-title":"J. Infect. Public Health"},{"issue":"2","key":"2026090104121830600_cit233","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1128\/jvi.66.2.971-982.1992","article-title":"Identification\nand Expression of Rpo19, a Vaccinia Virus Gene Encoding a 19-Kilodalton\nDNA-Dependent RNA Polymerase Subunit","volume":"66","author":"Ahn","year":"1992","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit234","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/ph15091129","article-title":"Fludarabine,\na Potential DNA-Dependent RNA Polymerase\nInhibitor, as a Prospective Drug against Monkeypox Virus: A Computational\nApproach","volume":"15","author":"Altayb","year":"2022","journal-title":"Pharmaceuticals"},{"key":"2026090104121830600_cit235","doi-asserted-by":"publisher","first-page":"1336490","DOI":"10.3389\/fmicb.2024.1336490","article-title":"Genistein Is Effective in Inhibiting Orf Virus\nInfection in Vitro\nby Targeting Viral RNA Polymerase Subunit RPO30 Protein","volume":"15","author":"Lv","year":"2024","journal-title":"Front. Microbiol."},{"issue":"10","key":"2026090104121830600_cit236","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tibs.2022.04.010","article-title":"Cytoplasmic Gene Expression:\nLessons from Poxviruses","volume":"47","author":"Grimm","year":"2022","journal-title":"Trends Biochem. Sci."},{"issue":"23","key":"2026090104121830600_cit237","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1038\/sj.emboj.7601912","article-title":"Structural Insights\ninto the Mechanism and Evolution of the Vaccinia Virus mRNA Cap N7Methyl-transferase","volume":"26","author":"De La Pen\u0303a","year":"2007","journal-title":"EMBO J."},{"issue":"3","key":"2026090104121830600_cit238","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.str.2013.12.014","article-title":"Crystal Structure of Vaccinia Virus\nmRNA Capping Enzyme Provides Insights into the Mechanism and Evolution\nof the Capping Apparatus","volume":"22","author":"Kyrieleis","year":"2014","journal-title":"Struct. London Engl.\n1993"},{"issue":"1","key":"2026090104121830600_cit239","doi-asserted-by":"publisher","first-page":"2369193","DOI":"10.1080\/22221751.2024.2369193","article-title":"Structural Basis of the Monkeypox\nVirus mRNA Cap N7Methyltransferase Complex","volume":"13","author":"Chen","year":"2024","journal-title":"Emerg. Microbes Infect."},{"issue":"23","key":"2026090104121830600_cit240","doi-asserted-by":"publisher","first-page":"16430","DOI":"10.1016\/S0021-9258(18)42021-2","article-title":"The Vaccinia Virus\nmRNA (Guanine-N7-)-Methyltransferase Requires Both Subunits of the\nmRNA Capping Enzyme for Activity","volume":"267","author":"Higman","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"39","key":"2026090104121830600_cit241","doi-asserted-by":"publisher","first-page":"24472","DOI":"10.1016\/S0021-9258(19)51108-5","article-title":"Intrinsic RNA (Guanine-7) Methyltransferase Activity\nof the Vaccinia Virus Capping Enzyme D1 Subunit Is Stimulated by the\nD12 Subunit. Identification of Amino Acid Residues in the D1 Protein\nRequired for Subunit Association and Methyl Group Transfer","volume":"269","author":"Mao","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2026090104121830600_cit242","doi-asserted-by":"publisher","first-page":"127565","DOI":"10.1016\/j.ijbiomac.2023.127565","article-title":"Crystal\nStructure of\nmRNA Cap (Guanine-N7) Methyltransferase E12 Subunit from Monkeypox\nVirus and Discovery of Its Inhibitors","volume":"253","author":"Wang","year":"2023","journal-title":"Int.\nJ. Biol. Macromol."},{"issue":"7","key":"2026090104121830600_cit243","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1073\/pnas.89.7.2897","article-title":"Cap-Specific mRNA (Nucleoside-O2\u2019-)-Methyltransferase\nand Poly(A) Polymerase Stimulatory Activities of Vaccinia Virus Are\nMediated by a Single Protein","volume":"89","author":"Schnierle","year":"1992","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"2","key":"2026090104121830600_cit244","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81101-0","article-title":"The 1.85\n\u00c5 Structure of Vaccinia Protein VP39: A Bifunctional Enzyme That\nParticipates in the Modification of Both mRNA Ends","volume":"85","author":"Hodel","year":"1996","journal-title":"Cell"},{"key":"2026090104121830600_cit245","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38019-1","article-title":"Discovery\nand\nStructural Characterization of Monkeypox Virus Methyltransferase VP39\nInhibitors Reveal Similarities to SARS-CoV-2 Nsp14 Methyltransferase","author":"Silhan","year":"2023","journal-title":"Nat. Commun."},{"key":"2026090104121830600_cit246","doi-asserted-by":"publisher","first-page":"105714","DOI":"10.1016\/j.antiviral.2023.105714","article-title":"Inhibitors of Mpox\nVP39 2\u2032-O\nMethyltransferase Efficiently Inhibit the Monkeypox Virus","volume":"218","author":"Zgarbova","year":"2023","journal-title":"Antiviral Res."},{"issue":"1","key":"2026090104121830600_cit247","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11030-024-10875-z","article-title":"Sinefungin\nAnalogs Targeting VP39 Methyltransferase as Potential Anti-Monkeypox\nTherapeutics: A Multi-Step Computational Approach","volume":"29","author":"Abouzied","year":"2025","journal-title":"Mol. Divers."},{"issue":"1","key":"2026090104121830600_cit248","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13065-024-01251-x","article-title":"Marine Fungal Diversity Unlocks Potent Antivirals against\nMonkeypox through Methyltransferase Inhibition Revealed by Molecular\nDynamics and Free Energy Landscape","volume":"18","author":"Alharbi","year":"2024","journal-title":"BMC Chem."},{"key":"2026090104121830600_cit249","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s12033-024-01246-y","article-title":"Targeting\nMonkeypox Virus Methyltransferase: Virtual Screening of Natural Compounds\nfrom Middle-Eastern Medicinal Plants","volume":"67","author":"Hashim","year":"2025","journal-title":"Mol. Biotechnol."},{"issue":"4","key":"2026090104121830600_cit250","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm00178a001","article-title":"S-Adenosyl-L-Methionine-Dependent\nMacromolecule Methyltransferases:\nPotential Targets for the Design of Chemotherapeutic Agents","volume":"23","author":"Borchardt","year":"1980","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026090104121830600_cit251","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.14.2.382-397.2001","article-title":"Vaccinia Virus Inhibitors as a Paradigm\nfor the Chemotherapy\nof Poxvirus Infections","volume":"14","author":"De Clercq","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"issue":"4341","key":"2026090104121830600_cit252","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1126\/science.200.4341.563","article-title":"(S)-9-(2,3-Dihydroxypropyl)Adenine: An Aliphatic Nucleoside Analog\nwith Broad-Spectrum Antiviral Activity","volume":"200","author":"De Clercq","year":"1978","journal-title":"Science"},{"issue":"5","key":"2026090104121830600_cit253","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/jm00191a010","article-title":"Antiviral Activity of Aliphatic Nucleoside\nAnalogs: Structure-Function Relationship","volume":"22","author":"De Clercq","year":"1979","journal-title":"J.\nMed. Chem."},{"issue":"1","key":"2026090104121830600_cit254","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0166-3542(83)90011-6","article-title":"Broad-Spectrum Antiviral Activity\nof the Carbocyclic Analog of 3-Deazaadenosine","volume":"3","author":"De Clercq","year":"1983","journal-title":"Antiviral Res."},{"issue":"1","key":"2026090104121830600_cit255","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1128\/AAC.28.1.84","article-title":"Antiviral and Antimetabolic Activities of Neplanocins","volume":"28","author":"De Clercq","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"2026090104121830600_cit256","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1128\/AAC.33.8.1291","article-title":"Broad-Spectrum Antiviral\nActivities of Neplanocin A, 3-Deazaneplanocin A, and Their 5\u2032-nor\nDerivatives","volume":"33","author":"De Clercq","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"2026090104121830600_cit257","first-page":"1063","article-title":"Biochemical Mode of\nCytotoxic Action of Neplanocin\na in L1210 Leukemic Cells1","volume":"46","author":"Inaba","year":"1986","journal-title":"Cancer Res."},{"issue":"7","key":"2026090104121830600_cit258","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/jm00127a007","article-title":"Synthesis of 3-Deazaneplanocin\nA, a Powerful Inhibitor\nof S-Adenosylhomocysteine Hydrolase with Potent and Selective in Vitro\nand in Vivo Antiviral Activities","volume":"32","author":"Tseng","year":"1989","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026090104121830600_cit259","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0166-3542(84)90012-3","article-title":"Broad-Spectrum\nAntiviral Activity of Adenosine Analogues","volume":"4","author":"De Clercq","year":"1984","journal-title":"Antiviral\nRes."},{"issue":"11","key":"2026090104121830600_cit260","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1128\/AAC.31.11.1849","article-title":"9-(Trans-2\u2019,Trans-3\u2032-Dihydroxycyclopent-4\u2019-Enyl)-Adenine\nand \u22123-Deazaadenine: Analogs of Neplanocin A Which Retain Potent\nAntiviral Activity but Exhibit Reduced Cytotoxicity","volume":"31","author":"Hasobe","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"2026090104121830600_cit261","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1021\/jm00030a014","article-title":"Antiviral Enantiomeric Preference for 5\u2032-Noraristeromycin","volume":"37","author":"Siddiqi","year":"1994","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026090104121830600_cit262","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/jm00080a018","article-title":"1. Synthesis of 6\u2019-Modified\nNeplanocin A Derivatives as Broad-Spectrum Antiviral Agents","volume":"35","author":"Shuto","year":"1992","journal-title":"J. Med. Chem."},{"issue":"24","key":"2026090104121830600_cit263","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1016\/j.bmc.2014.10.014","article-title":"Synthesis and Antiviral Activities\nof 3-Deaza-3-Fluoroaristeromycin\nand Its 5\u2032 Analogues","volume":"22","author":"Chen","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"2026090104121830600_cit264","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1016\/j.bmc.2014.07.051","article-title":"The Enantiomers\nof the 1\u2032,6\u2032-Isomer of\nNeplanocin A: Synthesis and Antiviral Properties","volume":"22","author":"Ye","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"2026090104121830600_cit265","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1128\/jvi.68.1.130-147.1994","article-title":"Assembly of\nVaccinia Virus: The Second Wrapping Cisterna Is Derived from the Trans\nGolgi Network","volume":"68","author":"Schmelz","year":"1994","journal-title":"J. Virol."},{"issue":"1","key":"2026090104121830600_cit266","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.antiviral.2011.11.010","article-title":"Deletion of the Vaccinia Virus F13L\nGene Results in a Highly Attenuated\nVirus That Mounts a Protective Immune Response against Subsequent\nVaccinia Virus Challenge","volume":"93","author":"Vliegen","year":"2012","journal-title":"Antiviral Res."},{"issue":"11","key":"2026090104121830600_cit267","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1128\/jvi.65.11.5910-5920.1991","article-title":"Extracellular Vaccinia Virus Formation\nand Cell-to-Cell Virus Transmission Are Prevented by Deletion of the\nGene Encoding the 37,000-Dalton Outer Envelope Protein","volume":"65","author":"Blasco","year":"1991","journal-title":"J. Virol."},{"issue":"6","key":"2026090104121830600_cit268","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/S1473-3099(18)30788-6","article-title":"Assessing a Drug for an Eradicated\nHuman Disease: US Food and Drug Administration Review of Tecovirimat\nfor the Treatment of Smallpox","volume":"19","author":"Chan-Tack","year":"2019","journal-title":"Lancet Infect.\nDis."},{"issue":"20","key":"2026090104121830600_cit269","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An Orally Bioavailable\nAntipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation\nand Protects Mice from Lethal Orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"2026090104121830600_cit270","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41564-025-01936-6","article-title":"Structural Insights into Tecovirimat\nAntiviral Activity and Poxvirus Resistance","volume":"10","author":"Vernuccio","year":"2025","journal-title":"Nat. Microbiol."},{"key":"2026090104121830600_cit271","doi-asserted-by":"publisher","first-page":"110532","DOI":"10.1016\/j.virol.2025.110532","article-title":"Emerging Variants of\nMpox Virus and Tecovirimat Resistance: Genomic Insights and Implications\nfor Treatment Strategies","volume":"608","author":"Chenchula","year":"2025","journal-title":"Virology"},{"issue":"7","key":"2026090104121830600_cit272","doi-asserted-by":"publisher","first-page":"e00568","DOI":"10.1128\/aac.00568-23","article-title":"Identification of Tecovirimat\nResistance-Associated Mutations in Human Monkeypox Virus - Los Angeles\nCounty","volume":"67","author":"Garrigues","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"2026090104121830600_cit273","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/135965350701200802","article-title":"Activity of the Anti-Orthopoxvirus\nCompound ST-246 against Vaccinia, Cowpox and Camelpox Viruses in Cell\nMonolayers and Organotypic Raft Cultures","volume":"12","author":"Duraffour","year":"2007","journal-title":"Antivir.\nTher."},{"issue":"7","key":"2026090104121830600_cit274","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/jm061484y","article-title":"N -(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-Dioxo-4,6- Ethenocycloprop[f]Isoindol-2-(1 H)-Yl)Carboxamides: Identification of Novel Orthopoxvirus\nEgress Inhibitors","volume":"50","author":"Bailey","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090104121830600_cit275","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat\nfor the Treatment\nof Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2026090104121830600_cit276","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1073\/pnas.0912134107","article-title":"Efficacy\nof ST-246 versus Lethal Poxvirus Challenge in Immunodeficient Mice","volume":"107","author":"Grosenbach","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"2026090104121830600_cit277","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1128\/AAC.00678-09","article-title":"ST-246\nInhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic\nDisease Manifestation","volume":"53","author":"Berhanu","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"2026090104121830600_cit278","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of Delayed\nTreatment with ST-246 Given Orally against Systemic Orthopoxvirus\nInfections in Mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"2026090104121830600_cit279","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of Orally\nDelivered ST-246 as Postexposure Prophylactic and Antiviral Therapeutic\nin an Aerosolized Rabbitpox Rabbit Model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral\nRes."},{"issue":"6","key":"2026090104121830600_cit280","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman Primates Are\nProtected from Smallpox Virus or Monkeypox Virus Challenges by the\nAntiviral Drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"2026090104121830600_cit281","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 Antiviral Efficacy\nin a Nonhuman Primate Monkeypox Model: Determination of the Minimal\nEffective Dose and Human Dose Justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"2026090104121830600_cit282","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective Antiviral\nTreatment of\nSystemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected\nwith Monkeypox Virus","volume":"85","author":"Smith","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit283","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","article-title":"Effects of Treatment\nDelay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox\nVirus Challenge in Cynomolgus Macaques","volume":"218","author":"Russo","year":"2018","journal-title":"J. Infect.\nDis."},{"issue":"9","key":"2026090104121830600_cit284","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1128\/AAC.00904-12","article-title":"Safety\nand Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 Following\na Single Daily Oral Dose for 14 Days in Human Volunteers","volume":"56","author":"Chinsangaram","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"2026090104121830600_cit285","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1128\/AAC.01689-09","article-title":"Safety and Pharmacokinetics\nof the Antiorthopoxvirus Compound ST-246 Following Repeat Oral Dosing\nin Healthy Adult Subjects","volume":"54","author":"Jordan","year":"2010","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"5","key":"2026090104121830600_cit286","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1128\/AAC.01303-07","article-title":"Single-Dose Safety and Pharmacokinetics\nof ST-246, a Novel Orthopoxvirus Egress Inhibitor","volume":"52","author":"Jordan","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"2026090104121830600_cit287","doi-asserted-by":"publisher","DOI":"10.3201\/eid2912.231146","article-title":"Tecovirimat Resistance\nin Mpox Patients, United States, 2022\u20132023","volume":"29","author":"Smith","year":"2023","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"2026090104121830600_cit288","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamainternmed.2023.7696","article-title":"Early Tecovirimat Treatment\nfor Mpox Disease Among People With HIV","volume":"184","author":"Aldred","year":"2024","journal-title":"JAMA\nInt. Med."},{"issue":"4","key":"2026090104121830600_cit289","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1084\/jem.129.4.795","article-title":"Inhibition of Release\nof Vaccinia Virus by N1-Isonicotinoly-N2\u20133-Methyl-4-Chlorobenzoylhydrazine","volume":"129","author":"Kato","year":"1969","journal-title":"J. Exp. Med."},{"issue":"2","key":"2026090104121830600_cit290","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1128\/jvi.32.2.614-622.1979","article-title":"Mechanism\nof Vaccinia Virus Release\nand Its Specific Inhibition by N1 -Isonicotinoyl- N2 \u22123-Methyl-4- Chlorobenzoylhydrazine","volume":"32","author":"Payne","year":"1979","journal-title":"J. Virol."},{"issue":"7","key":"2026090104121830600_cit291","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/jvi.65.7.3435-3442.1991","article-title":"A Mutation\nin the Gene Encoding the Vaccinia Virus 37,000-M(r) Protein Confers\nResistance to an Inhibitor of Virus Envelopment and Release","volume":"65","author":"Schmutz","year":"1991","journal-title":"J. Virol."},{"issue":"5","key":"2026090104121830600_cit292","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 Is a Key Antiviral\nto Inhibit the Viral F13L Phospholipase, One of the Essential Proteins\nfor Orthopoxvirus Wrapping","volume":"70","author":"Duraffour","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"2026090104121830600_cit293","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1099\/jgv.0.000422","article-title":"New\nEffective Chemically Synthesized Anti-Smallpox Compound NIOCH-14","volume":"97","author":"Mazurkov","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"12","key":"2026090104121830600_cit294","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/cmdc.201000306","article-title":"Polycyclic N -Benzamido Imides with\nPotent Activity against Vaccinia\nVirus","volume":"5","author":"Torres","year":"2010","journal-title":"ChemMedChem."},{"key":"2026090104121830600_cit295","doi-asserted-by":"publisher","first-page":"118447","DOI":"10.1016\/j.ejmech.2025.118447","article-title":"Ligand-Based Design and Optimization of Tecovirimat\nDerivatives as Potent Antiviral Agents against Monkeypox Virus","volume":"303","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026090104121830600_cit296","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/v15010029","article-title":"Structure-Based Design, Synthesis, and Biological\nEvaluation of the\nCage\u2013Amide Derived Orthopox Virus Replication Inhibitors","volume":"15","author":"Mozhaitsev","year":"2023","journal-title":"Viruses"},{"issue":"10","key":"2026090104121830600_cit297","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1039\/D0MD00108B","article-title":"New chemical agents based on adamantane\u2013monoterpene\nconjugates\nagainst orthopoxvirus infections","volume":"11","author":"Suslov","year":"2020","journal-title":"RSC Med. Chem."},{"key":"2026090104121830600_cit298","doi-asserted-by":"publisher","first-page":"113485","DOI":"10.1016\/j.ejmech.2021.113485","article-title":"Adamantane Derivatives as Potential Inhibitors of P37\nMajor Envelope Protein and Poxvirus Reproduction. Design, Synthesis\nand Antiviral Activity","volume":"221","author":"Shiryaev","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"2026090104121830600_cit299","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/chemistry7020034","article-title":"Anti-Orthopoxvirus\nActivity\nof Amantadine and Rimantadine Derivatives\u2500In Vitro Testing\nand Molecular Modeling","volume":"7","author":"Moskalev","year":"2025","journal-title":"Chemistry"},{"issue":"5","key":"2026090104121830600_cit300","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1021\/acsmedchemlett.5c00075","article-title":"Discovery\nof p -Trifluoromethylbenzohydrazide Derivatives as\nPotent Antiviral\nAgents against Monkeypox Virus","volume":"16","author":"Rossi","year":"2025","journal-title":"ACS Med. Chem.\nLett."},{"key":"2026090104121830600_cit301","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67487-w","article-title":"Development\nof a Replication-Defective Mpox Virus Platform for Fundamental and\nTherapeutic Research","author":"Chen","year":"2026","journal-title":"Nat. Commun."},{"key":"2026090104121830600_cit372","doi-asserted-by":"publisher","first-page":"118124","DOI":"10.1016\/j.ejmech.2025.118124","article-title":"Expanding\nthe Antiviral Arsenal: N-Arylated 1,2,4-Oxadiazol-5(4H)-Ones Show\nHigh Activity against Orthopoxviruses","volume":"300","author":"Semenov","year":"2025","journal-title":"Eur.\nJ. Med. Chem."},{"issue":"1","key":"2026090104121830600_cit371","doi-asserted-by":"publisher","first-page":"2373309","DOI":"10.1080\/22221751.2024.2373309","article-title":"Identification\nof the VP37 Pocket of Monkeypox Virus\nas a Promising Target for Pan-Orthopoxvirus Inhibitors through Virtual\nScreening and Antiviral Assays","volume":"13","author":"Huo","year":"2024","journal-title":"Emerg. Microbes\nInfect."},{"issue":"6","key":"2026090104121830600_cit302","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1083\/jcb.200504026","article-title":"External Scaffold\nof Spherical Immature Poxvirus Particles Is Made\nof Protein Trimers, Forming a Honeycomb Lattice","volume":"170","author":"Szajner","year":"2005","journal-title":"J. Cell Biol."},{"issue":"7","key":"2026090104121830600_cit303","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.str.2011.03.023","article-title":"Insights\ninto the Evolution of a Complex Virus from the Crystal Structure of\nVaccinia Virus D13","volume":"19","author":"Bahar","year":"2011","journal-title":"Structure"},{"issue":"5226","key":"2026090104121830600_cit304","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/2241280a0","article-title":"Rifampicin:\nA Specific Inhibitor of Vaccinia Virus Assembly","volume":"224","author":"Moss","year":"1969","journal-title":"Nature"},{"issue":"2","key":"2026090104121830600_cit305","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1128\/jvi.68.2.1103-1114.1994","article-title":"Assembly\nof Vaccinia Virus: Effects of Rifampin on\nthe Intracellular Distribution of Viral Protein P65","volume":"68","author":"Sodeik","year":"1994","journal-title":"J. Virol."},{"issue":"33","key":"2026090104121830600_cit306","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1810398115","article-title":"Structural\nBasis for the Inhibition\nof Poxvirus Assembly by the Antibiotic Rifampicin","volume":"115","author":"Garriga","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"2026090104121830600_cit307","doi-asserted-by":"publisher","first-page":"14259","DOI":"10.1080\/07391102.2023.2183342","article-title":"In Silico Discovery of Potent Inhibitors against\nMonkeypox\u2019s Major\nStructural Proteins","volume":"41","author":"Lokhande","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"2026090104121830600_cit308","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/138161206776361110","article-title":"Antiviral Drug Discovery\nTargeting to Viral Proteases","volume":"12","author":"Hsu","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"17","key":"2026090104121830600_cit309","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1128\/JVI.76.17.8973-8976.2002","article-title":"The Vaccinia Virus\nI7L Gene Product Is The Core Protein Proteinase","volume":"76","author":"Byrd","year":"2002","journal-title":"J. Virol."},{"issue":"3","key":"2026090104121830600_cit310","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/rmv.499","article-title":"Vaccinia Virus Proteolysis\u2500a\nReview","volume":"16","author":"Byrd","year":"2006","journal-title":"Rev. Med. Virol."},{"issue":"20","key":"2026090104121830600_cit311","doi-asserted-by":"publisher","first-page":"11279","DOI":"10.1128\/JVI.77.20.11279-11283.2003","article-title":"Molecular\nDissection\nof the Vaccinia Virus I7L Core Protein Proteinase","volume":"77","author":"Byrd","year":"2003","journal-title":"J. Virol."},{"issue":"12","key":"2026090104121830600_cit312","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1128\/JVI.78.12.6335-6343.2004","article-title":"Role of the I7 Protein\nin Proteolytic\nProcessing of Vaccinia Virus Membrane and Core Components","volume":"78","author":"Ansarah-Sobrinho","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"2026090104121830600_cit313","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1743-422X-2-4","article-title":"A Conditional-Lethal\nVaccinia Virus\nMutant Demonstrates That the I7L Gene Product Is Required for Virion\nMorphogenesis","volume":"2","author":"Byrd","year":"2005","journal-title":"Virol. J."},{"issue":"8070","key":"2026090104121830600_cit314","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-025-09014-x","article-title":"Substrate Recognition and Cleavage Mechanism\nof the Monkeypox Virus\nCore Protease","volume":"643","author":"Gao","year":"2025","journal-title":"Nature"},{"key":"2026090104121830600_cit315","doi-asserted-by":"publisher","first-page":"2501625","DOI":"10.1002\/advs.202501625","article-title":"Dynamic\nCap-mediated Substrate Access and Potent Inhibitor Design of Monkeypox\nVirus I7L Protease","volume":"12","author":"Su","year":"2025","journal-title":"Adv. Sci."},{"issue":"22","key":"2026090104121830600_cit316","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","article-title":"New Class of Orthopoxvirus Antiviral\nDrugs That Block Viral Maturation","volume":"78","author":"Byrd","year":"2004","journal-title":"J. Virol."},{"issue":"8","key":"2026090104121830600_cit317","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.3390\/ijms24087119","article-title":"Targeting the I7L Protease:\nA Rational Design for Anti-Monkeypox Drugs?","volume":"24","author":"Dodaro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2026090104121830600_cit318","doi-asserted-by":"publisher","first-page":"106971","DOI":"10.1016\/j.compbiomed.2023.106971","article-title":"Identification of\nCore Therapeutic Targets for Monkeypox Virus and Repurposing Potential\nof Drugs against Them: An in Silico Approach","volume":"161","author":"Sahu","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"2026090104121830600_cit370","doi-asserted-by":"publisher","first-page":"fnaf008","DOI":"10.1093\/femsle\/fnaf008","article-title":"In Vitro Enzyme Characterization and Several Inhibitors\nfor Monkeypox Virus Core Protease I7L. FEMS","volume":"372","author":"Wei","year":"2025","journal-title":"Microbiol. Lett."},{"issue":"5","key":"2026090104121830600_cit319","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/JVI.02247-09","article-title":"The Structure\nof the Poxvirus A33 Protein Reveals a Dimer of Unique C-Type Lectin-Like\nDomains","volume":"84","author":"Su","year":"2010","journal-title":"J. Virol."},{"key":"2026090104121830600_cit320","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1128\/jvi.66.7.4170-4179.1992","article-title":"Role of Cell-Associated\nEnveloped\nVaccinia Virus in Cell-to-Cell Spread","volume":"66","author":"Blasco","year":"1992","journal-title":"J. VIROL"},{"issue":"7","key":"2026090104121830600_cit321","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1128\/JVI.77.7.4113-4126.2003","article-title":"Mapping and\nFunctional\nAnalysis of Interaction Sites within the Cytoplasmic Domains of the\nVaccinia Virus A33R and A36R Envelope Proteins","volume":"77","author":"Ward","year":"2003","journal-title":"J. Virol."},{"issue":"4","key":"2026090104121830600_cit322","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1099\/vir.0.049486-0","article-title":"Transport\nand Stability of the Vaccinia Virus A34 Protein Is Affected by the\nA33 Protein","volume":"94","author":"Breiman","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"7","key":"2026090104121830600_cit323","doi-asserted-by":"publisher","first-page":"e02155","DOI":"10.1128\/JVI.02155-19","article-title":"Vaccinia Virus Glycoproteins A33,\nA34, and B5 Form\na Complex for Efficient Endoplasmic Reticulum to Trans -Golgi Network Transport","volume":"94","author":"Monticelli","year":"2020","journal-title":"J. Virol."},{"issue":"15","key":"2026090104121830600_cit324","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1128\/JVI.00249-12","article-title":"The A33-Dependent Incorporation of\nB5 into Extracellular Enveloped Vaccinia Virions Is Mediated through\nan Interaction between Their Lumenal Domains","volume":"86","author":"Chan","year":"2012","journal-title":"J. Virol."},{"issue":"7","key":"2026090104121830600_cit325","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/vaccines10071084","article-title":"Protective Human Anti-Poxvirus Monoclonal\nAntibodies Are Generated from Rare Memory B Cells Isolated by Multicolor\nAntigen Tetramers","volume":"10","author":"Gu","year":"2022","journal-title":"Vaccines"},{"issue":"17","key":"2026090104121830600_cit326","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of\nChimpanzee\/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein\nand Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse\nProtection Model","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"issue":"9","key":"2026090104121830600_cit327","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005148","article-title":"Structural and Functional\nCharacterization of Anti-A33 Antibodies Reveal a Potent Cross-Species\nOrthopoxviruses Neutralizer","volume":"11","author":"Matho","year":"2015","journal-title":"PLOS Pathog."},{"issue":"8","key":"2026090104121830600_cit328","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1128\/jvi.67.8.4732-4741.1993","article-title":"Deletion of the Vaccinia\nVirus B5R Gene Encoding a 42-Kilodalton Membrane Glycoprotein Inhibits\nExtracellular Virus Envelope Formation and Dissemination","volume":"67","author":"Wolffe","year":"1993","journal-title":"J. Virol."},{"key":"2026090104121830600_cit329","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1099\/vir.0.009092-0","article-title":"Acidic\nResidues\nin the Membrane-Proximal Stalk Region of Vaccinia Virus Protein B5\nAre Required for Glycosaminoglycan-Mediated Disruption of the Extracellular\nEnveloped Virus Outer Membrane","volume":"90","author":"Roberts","year":"2009","journal-title":"Journal of General\nVirology"},{"issue":"15","key":"2026090104121830600_cit330","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1073\/pnas.0601025103","article-title":"Ligand-induced and nonfusogenic dissolution of a viral\nmembrane","volume":"103","author":"Law","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"2026090104121830600_cit331","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The Vaccinia Virus 42-kDa Envelope\nProtein Is Required for the Envelopment and Egress of Extracellular\nVirus and for Virus Virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"issue":"9","key":"2026090104121830600_cit332","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1099\/vir.0.043943-0","article-title":"Protein\nB5 Is Required on Extracellular Enveloped Vaccinia\nVirus for Repulsion of Superinfecting Virions","volume":"93","author":"Doceul","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"6","key":"2026090104121830600_cit333","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/Human\nmAbs\nto Vaccinia Virus B5 Protein Neutralize Vaccinia and Smallpox Viruses\nand Protect Mice against Vaccinia Virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"issue":"11","key":"2026090104121830600_cit334","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048706","article-title":"Protection of Rabbits\nand Immunodeficient\nMice against Lethal Poxvirus Infections by Human Monoclonal Antibodies","volume":"7","author":"Crickard","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2026090104121830600_cit335","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1038\/s41467-024-48312-2","article-title":"Two Noncompeting Human Neutralizing Antibodies Targeting\nMPXV B6 Show Protective Effects against Orthopoxvirus Infections","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"2026090104121830600_cit336","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing\nand Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"issue":"1","key":"2026090104121830600_cit337","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/viro.1997.8684","article-title":"Novobiocin Inhibits Vaccinia Virus\nReplication by Blocking Virus Assembly","volume":"235","author":"Sekiguchi","year":"1997","journal-title":"Virology"},{"issue":"3","key":"2026090104121830600_cit338","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.antiviral.2010.09.017","article-title":"Inhibition of\nPoxvirus Growth by Terameprocol, a Methylated Derivative of Nordihydroguaiaretic\nAcid","volume":"88","author":"Pollara","year":"2010","journal-title":"Antiviral Res."},{"issue":"24","key":"2026090104121830600_cit339","doi-asserted-by":"publisher","first-page":"13392","DOI":"10.1128\/JVI.00770-07","article-title":"Identification of Novel\nAntipoxviral\nAgents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking\nVirion Assembly","volume":"81","author":"Deng","year":"2007","journal-title":"J. Virol."},{"issue":"3","key":"2026090104121830600_cit340","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.celrep.2013.06.028","article-title":"Vaccinia Virus Entry Is Followed by Core Activation\nand Proteasome-Mediated Release of the Immunomodulatory Effector VH1\nfrom Lateral Bodies","volume":"4","author":"Schmidt","year":"2013","journal-title":"Cell Rep."},{"issue":"4","key":"2026090104121830600_cit341","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1042\/BST20200408","article-title":"Revisiting\nVH1 Phosphatase at the Time of Monkeypox: Back to the Spotlight","volume":"51","author":"Bottini","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"2026090104121830600_cit342","doi-asserted-by":"publisher","first-page":"7823","DOI":"10.1128\/jvi.69.12.7823-7834.1995","article-title":"The Dual-Specificity\nPhosphatase\nEncoded by Vaccinia Virus, VH1, Is Essential for Viral Transcription\nin Vivo and in Vitro","volume":"69","author":"Liu","year":"1995","journal-title":"J. Virol."},{"issue":"7","key":"2026090104121830600_cit343","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/JVI.75.7.3185-3196.2001","article-title":"Vaccinia Virus Blocks\nGamma Interferon Signal Transduction: Viral VH1 Phosphatase Reverses\nStat1 Activation","volume":"75","author":"Najarro","year":"2001","journal-title":"J. Virol."},{"issue":"16","key":"2026090104121830600_cit344","doi-asserted-by":"publisher","first-page":"14373","DOI":"10.1074\/jbc.M111.226357","article-title":"Dimerization\nof Vaccinia Virus VH1\nIs Essential for Dephosphorylation of STAT1 at Tyrosine 701","volume":"286","author":"Koksal","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"15","key":"2026090104121830600_cit345","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1074\/jbc.M808362200","article-title":"Dimeric Quaternary\nStructure of the Prototypical Dual Specificity Phosphatase VH1","volume":"284","author":"Koksal","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026090104121830600_cit346","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/jir.2007.0113","article-title":"Vaccinia Virus Blocks\nStat1-Dependent and Stat1-Independent Gene Expression Induced by Type\nI and Type II Interferons","volume":"28","author":"Mann","year":"2008","journal-title":"J. Interferon Cytokine\nRes."},{"issue":"5","key":"2026090104121830600_cit347","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41564-018-0142-6","article-title":"Proteotype Profiling\nUnmasks a Viral Signalling Network Essential for Poxvirus Assembly\nand Transcriptional Competence","volume":"3","author":"Novy","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"9","key":"2026090104121830600_cit348","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.1128\/JVI.73.9.7287-7296.1999","article-title":"Tyrosine Phosphorylation\nof A17 during Vaccinia Virus\nInfection: Involvement of the H1 Phosphatase and the F10 Kinase","volume":"73","author":"Derrien","year":"1999","journal-title":"J. Virol."},{"issue":"8","key":"2026090104121830600_cit349","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1128\/JVI.74.8.3682-3695.2000","article-title":"Elucidating the Essential\nRole of\nthe A14 Phosphoprotein in Vaccinia Virus Morphogenesis: Construction\nand Characterization of a Tetracycline-Inducible Recombinant","volume":"74","author":"Traktman","year":"2000","journal-title":"J. Virol."},{"key":"2026090104121830600_cit350","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwac051","article-title":"Crystal Structure of Monkeypox H1 Phosphatase,\nan Antiviral\nDrug Target","author":"Cui","year":"2022","journal-title":"Protein Cell"},{"issue":"11","key":"2026090104121830600_cit351","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/v17111493","article-title":"High-Throughput Discovery of Inhibitors Targeting Monkeypox Virus\nH1 Phosphatase","volume":"17","author":"Tao","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"2026090104121830600_cit352","doi-asserted-by":"publisher","first-page":"2535585","DOI":"10.1080\/14756366.2025.2535585","article-title":"A Study\nof Flavonoid\nInhibitors against Monkeypox H1 Phosphatase","volume":"40","author":"Kim","year":"2025","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"2026090104121830600_cit353","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/vaccines8030401","article-title":"Identification\nof Vaccinia Virus Inhibitors and Cellular Functions Necessary for\nEfficient Viral Replication by Screening Bioactives and FDA-Approved\nDrugs","volume":"8","author":"Peng","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"2026090104121830600_cit354","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2011.10.020","article-title":"SP600125\nInhibits Orthopoxviruses Replication in a JNK1\/2 -Independent Manner:\nImplication as a Potential Antipoxviral","volume":"93","author":"Pereira","year":"2012","journal-title":"Antiviral\nRes."},{"issue":"1","key":"2026090104121830600_cit355","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0042-6822(88)90635-6","article-title":"Cell Proliferative\nResponse to Vaccinia Virus Is Mediated by VGF","volume":"164","author":"Buller","year":"1988","journal-title":"Virology"},{"issue":"3","key":"2026090104121830600_cit356","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1128\/jvi.62.3.866-874.1988","article-title":"Deletion of the Vaccinia Virus Growth Factor Gene Reduces Virus Virulence","volume":"62","author":"Buller","year":"1988","journal-title":"J. Virol."},{"issue":"24","key":"2026090104121830600_cit357","doi-asserted-by":"publisher","first-page":"25838","DOI":"10.1074\/jbc.M400343200","article-title":"Biochemical and Functional\nAnalysis of Smallpox Growth Factor (SPGF) and Anti-SPGF Monoclonal\nAntibodies","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"2026090104121830600_cit358","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral\nChemotherapy Facilitates Control of Poxvirus Infections through Inhibition\nof Cellular Signal Transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"1","key":"2026090104121830600_cit359","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.antiviral.2010.11.006","article-title":"Inhibition\nof Poxvirus Spreading by the Anti-Tumor Drug Gefitinib (IressaTM)","volume":"89","author":"Langhammer","year":"2011","journal-title":"Antiviral Res."},{"issue":"7","key":"2026090104121830600_cit360","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/bph.17466","article-title":"Advances in Bruton Tyrosine Kinase (Btk) Inhibition Are Steered by\nBruton Tyrosine Kinase Phylogeny","volume":"182","author":"Minotti","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"2026090104121830600_cit361","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-065X.2008.00741.x","article-title":"Bruton\u2019s\nTyrosine Kinase (Btk): Function, Regulation, and Transformation with\nSpecial Emphasis on the PH Domain","volume":"228","author":"Mohamed","year":"2009","journal-title":"Immunol.\nRev."},{"issue":"9","key":"2026090104121830600_cit362","doi-asserted-by":"publisher","first-page":"e00517","DOI":"10.1128\/jvi.00517-25","article-title":"Ibrutinib\nInhibits the Replication of Multiple Poxviruses by Targeting the Bruton\nTyrosine Kinase","volume":"99","author":"Niu","year":"2025","journal-title":"J. Virol."},{"issue":"7975","key":"2026090104121830600_cit363","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41586-023-06401-0","article-title":"TRIM5\u03b1 Restricts\nPoxviruses and Is Antagonized by CypA and the Viral Protein C6","volume":"620","author":"Zhao","year":"2023","journal-title":"Nature"},{"issue":"16","key":"2026090104121830600_cit364","doi-asserted-by":"publisher","first-page":"9052","DOI":"10.1128\/JVI.77.16.9052-9068.2003","article-title":"Redistribution of Cyclophilin A to Viral Factories\nduring Vaccinia Virus Infection and Its Incorporation into Mature\nParticles","volume":"77","author":"Castro","year":"2003","journal-title":"J. Virol."},{"key":"2026090104121830600_cit365","doi-asserted-by":"publisher","first-page":"106204","DOI":"10.1016\/j.antiviral.2025.106204","article-title":"Suppression of Poxvirus\nReplication\nby SC144","volume":"240","author":"Pant","year":"2025","journal-title":"Antiviral Res."},{"issue":"6670","key":"2026090104121830600_cit366","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.adg8116","article-title":"APOBEC3\nDeaminase Editing in Mpox Virus as Evidence for Sustained Human Transmission\nsince at Least 2016","volume":"382","author":"O\u2019Toole","year":"2023","journal-title":"Science"},{"issue":"6","key":"2026090104121830600_cit367","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1128\/AAC.01626-08","article-title":"Inhibition\nof Vaccinia Virus Replication\nby Two Small Interfering RNAs Targeting B1R and G7L Genes and Their\nSynergistic Combination with Cidofovir","volume":"53","author":"Vigne","year":"2009","journal-title":"Antimicrob.\nAgents Chemother."},{"issue":"5","key":"2026090104121830600_cit368","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28783","article-title":"Mapping and Characterization of G-quadruplexes\nin Monkeypox\nGenomes","volume":"95","author":"Pereira","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"2026090104121830600_cit369","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12879-024-09332-x","article-title":"Expression Analysis\nand Mapping of Viral\u2500Host\nProtein Interactions of Poxviridae Suggests a Lead Candidate Molecule\nTargeting Mpox","volume":"24","author":"Loganathan","year":"2024","journal-title":"BMC Infect. Dis."}],"container-title":["Chemical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.chemrev.6c00118","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/chreay\/article-pdf\/126\/16\/9307\/66566026\/acs.chemrev.6c00118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/chreay\/article-pdf\/126\/16\/9307\/66566026\/acs.chemrev.6c00118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:12:36Z","timestamp":1788250356000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/chreay\/article\/126\/16\/9307\/5256606\/Insights-into-the-Life-Cycle-and-Therapeutic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":377,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,8,26]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.chemrev.6c00118","relation":{},"ISSN":["0009-2665","1520-6890"],"issn-type":[{"value":"0009-2665","type":"print"},{"value":"1520-6890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}